Valvular heart disease excluding rheumatic fever

I9_VHD

heart valve disease: A disease involving the cardial valve.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints I9_NONRHEVALV I9_VALVES	29522
6. Filter based on genotype QC (FinnGen only)	29522

Control definitions (FinnGen only)

Control exclude: I9_OTHHEART

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	I9_VHD
CONTROL_EXCLUDE	I9_OTHHEART
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	I9_NONRHEVALV\|I9_VALVES
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Valvular heart disease excluding rheumatic fever based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	217192	107750	107449
Only index persons	176491	88289	88202
Unadjusted period prevalence (%)
Whole population	3.04	3.09	3.00
Only index persons	3.31	3.25	3.37
Median age at first event (years)
Whole population	71.71	74.29	69.13
Only index persons	71.19	73.61	68.76

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	29522	12675	16847
Unadjusted period prevalence (%)	6.09	4.32	7.43
Median age at first event (years)	69.17	69.52	68.91

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
13763: Matched controls
119745

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

PD5BD

NOMESCO Finland

Extensive CT of aorta

14.5

323.3

581

362

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

12.7

323.0

5211

5466

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

5.6

323.0

3525

6894

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

367.8

323.0

951

I47.1

ICD-10 Finland

Supraventricular tachycardia

45.8

323.0

658

131

I50.9

ICD-10 Finland

Heart failure, unspecified

126.8

323.0

2468

206

FMD10

NOMESCO Finland

Replacement of aortic valve using biological prosthesis

+∞

323.0

878

201

Kela drug reimbursment

Chronic cardiac insufficiency

29.1

323.0

1093

354

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

24.4

323.0

3187

1462

AN1

Coronary angiography

5.7

323.0

2218

3927

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

12.2

323.0

2765

2408

FMD00

NOMESCO Finland

Replacement of aortic valve using mechanical prosthesis

+∞

323.0

736

C03DA01

ATC

spironolactone; oral

5.8

323.0

1900

3222

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

789.1

323.0

3577

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

520.1

323.0

684

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

728.0

323.0

4532

XF402

NOMESCO Finland

ECG with work load test

4.8

323.0

2286

4761

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

123.9

323.0

1303

101

TFP34

NOMESCO Finland

Electrophysiological investigation

614.4

323.0

609

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

6.7

323.0

1684

2430

C01BD01

ATC

amiodarone; systemic

511.8

323.0

727

FKB10

NOMESCO Finland

Annuloplasty of mitral valve for insufficiency using ring

+∞

323.0

776

C01AA05

ATC

digoxin; systemic

31.3

323.0

1388

428

XF404

NOMESCO Finland

Ambulatory ECG

13.0

323.0

2115

1650

I71.9

ICD-10 Finland

Aortic aneurysm of unspecified site, without mention of rupture

22.0

323.0

508

208

I48.2

ICD-10 Finland

Chronic atrial fibrillation

2035.5

323.0

470

XF400

NOMESCO Finland

ECG with 12 standard connections

2.9

323.0

2437

8371

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

3071.2

323.0

353

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

8.6

323.0

824

885

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

5.2

323.0

1476

2707

207

Kela drug reimbursment

Chronic arrhythmias

367.4

323.0

2777

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

28.9

323.0

1317

437

C09AA05

ATC

ramipril; oral

2.9

323.0

3752

13755

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

36.3

323.0

2301

659

TFP20

NOMESCO Finland

Cardiodefibrillation

361.5

323.0

1884

FKC50

NOMESCO Finland

Repair of mitral valve for insufficiency using prosthetic chord

+∞

323.0

448

C01BC04

ATC

flecainide; systemic

124.3

323.0

536

I25.1

ICD-10 Finland

Atherosclerotic heart disease

4.2

323.0

3411

8660

XFE00

NOMESCO Finland

Epicardial ultrasonography

14.9

323.0

663

404

B01AF02

ATC

apixaban; oral

13.8

323.0

1421

993

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.8

323.0

3079

11204

I34.9

ICD-10 Finland

Nonrheumatic mitral valve disorder, unspecified

1337.9

323.0

439

I34.01

ICD-10 Finland

Mitral (valve) regurgitation NOS or of specified cause, except rheumatic

1777.1

323.0

414

C07AB02

ATC

metoprolol; systemic

2.9

323.0

2851

9808

C07AB07

ATC

bisoprolol; oral

6.0

323.0

8644

26346

B01AB05

ATC

enoxaparin; parenteral

2.3

323.0

4521

21297

I50.1

ICD-10 Finland

Left ventricular failure

1695.8

323.0

955

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

+∞

323.0

2132

I44.2

ICD-10 Finland

Atrioventricular block, complete

+∞

323.0

460

FME20

NOMESCO Finland

Transvenous aortic valve replacement via femoral artery

2861.5

323.0

330

K83

ICPC

Heart valve disease NOS

247.9

323.0

676

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

17.0

323.0

7331

7510

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

160.4

323.0

717

I49.3

ICD-10 Finland

Ventricular premature depolarization

17.8

323.0

1177

627

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

554.2

323.0

1635

R06.0

ICD-10 Finland

Dyspnoea

2.8

323.0

3637

13733

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

3280.7

323.0

1398

I36.1

ICD-10 Finland

Nonrheumatic tricuspid (valve) insufficiency

1300.0

323.0

702

XF640

NOMESCO Finland

20.7

323.0

896

401

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

162.7

323.0

974

WX872

NOMESCO Finland

Intensive care

13.1

323.0

1935

1481

I47.2

ICD-10 Finland

Ventricular tachycardia

229.3

323.0

409

I48.1

ICD-10 Finland

Persistent atrial fibrillation

505.4

323.0

451

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

6.3

323.0

1022

1511

I34.0

ICD-10 Finland

Mitral (valve) insufficiency

124.0

323.0

831

I42.0

ICD-10 Finland

Dilated cardiomyopathy

1031.6

323.0

569

I50.0

ICD-10 Finland

Congestive heart failure

228.2

323.0

1220

K78

ICPC

Atrial fibrillation/flutter

35.8

323.0

1333

357

I49.5

ICD-10 Finland

Sick sinus syndrome

332.2

323.0

518

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

244.8

323.0

1254

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.6

323.0

7603

30444

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

729.3

323.0

1498

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

977.2

323.0

2490

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

88.6

323.0

742

B01AA03

ATC

warfarin; systemic

19.3

323.0

5379

3850

I48

ICD-10 Finland

Atrial fibrillation and flutter

208.3

323.0

4417

271

C03CA01

ATC

furosemide; systemic

5.8

323.0

4849

10279

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

8.5

323.0

5597

8946

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

39.8

323.0

909

212

I35.0

ICD-10 Finland

Aortic (valve) stenosis

454.9

323.0

4001

109

I34.1

ICD-10 Finland

Mitral (valve) prolapse

648.9

323.0

2758

Q23.11

ICD-10 Finland

Bicuspid aortic valve

135.2

323.0

805

FM1DG

NOMESCO Finland

Very extensive MRI examination of heart with high intesity magnet

50.3

322.5

410

ZXE20

NOMESCO Finland

More than three and less than five hours

2.8

317.0

2342

8041

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

2.9

316.7

2206

7291

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

368.0

313.9

332

K84

ICPC

Heart disease other

11.8

313.1

618

476

TPH07

NOMESCO Finland

Cathetrisation of artery

3.3

312.1

1784

5126

I10

ICD-10 Finland

Essential (primary) hypertension

2.0

310.6

7751

47231

AC4

MVP

+∞

301.3

304

C01DA14

ATC

isosorbide mononitrate; oral

3.3

289.4

1689

4911

ZXD05

NOMESCO Finland

Urgent procedure

2.1

284.9

4078

19659

R07.4

ICD-10 Finland

Chest pain, unspecified

2.2

279.3

3730

17409

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

4.5

278.9

1093

2252

I50

ICD-10 Finland

Heart failure

32.9

276.4

383

104

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

8.1

273.0

663

745

TFP46

NOMESCO Finland

Ablation treatment of atrial fibrillation

+∞

272.4

275

TFP35

NOMESCO Finland

Electroanatomical mapping

627.1

272.1

283

AB1

AVR mechanical

2353.9

269.0

274

TFP00

NOMESCO Finland

Temporary use of transvenous or epicardial pacemaker

73.6

268.5

322

I35.9

ICD-10 Finland

Aortic valve disorder, unspecified

414.1

266.8

281

R01.1

ICD-10 Finland

Cardiac murmur, unspecified

9.2

265.8

596

585

AA1AD

NOMESCO Finland

CT of head and brain

2.2

259.1

3125

13839

C10AA05

ATC

atorvastatin; oral

1.9

258.4

5319

29397

WX892

NOMESCO Finland

Monitored bed care

3.8

253.3

1209

2981

C07AA07

ATC

sotalol; systemic

10.4

249.6

522

450

FKC60

NOMESCO Finland

Resection and reconstruction of leaflet of mitral valve for insufficiency

+∞

246.6

249

Angiography of the heart and coronary arteries

5.1

240.3

835

1509

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

282.4

240.1

257

ZXE30

NOMESCO Finland

More than five and less than seven hours

4.1

237.7

1022

2292

TPH04

NOMESCO Finland

Cathetrisation of vein

2.2

236.8

2839

12460

TFC25

NOMESCO Finland

Transseptal catheterisation of left atrium or ventricle

+∞

235.6

238

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.0

234.6

3941

19974

I49.1

ICD-10 Finland

Atrial premature depolarization

12.5

231.3

442

316

I44.1

ICD-10 Finland

Atrioventricular block, second degree

246.1

230.9

249

WX408

NOMESCO Finland

General anesthesy, balanced

2.0

227.5

3912

19959

FCA60

NOMESCO Finland

Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of composite graft with mechanical valve prosthesis

216.9

225.6

245

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

125.5

225.6

255

K99

ICPC

Cardiovascular disease other

9.2

218.1

487

473

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

5.7

217.1

681

1090

I34.2

ICD-10 Finland

Nonrheumatic mitral (valve) stenosis

+∞

213.8

216

FKC20

NOMESCO Finland

Plastic repair of mitral valve leaflet for insufficiency

+∞

211.8

214

N02BE01

ATC

paracetamol; systemic, rectal

2.0

210.2

11358

84376

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.6

210.2

1747

6308

AB2

AVR bio, stent

+∞

204.8

207

FKD10

NOMESCO Finland

Replacement of mitral valve using biological prosthesis

+∞

204.8

207

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

2.4

204.8

2057

8220

K80

ICPC

Cardiac arrhythmia NOS

3.9

203.9

931

2196

Z95.3

ICD-10 Finland

Presence of xenogenic heart valve

620.1

202.7

211

B01AC04

ATC

clopidogrel; oral

2.4

199.9

1911

7435

Z95.8

ICD-10 Finland

Presence of other cardiac and vascular implants and grafts

91.3

194.5

227

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

4.2

192.9

806

1751

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

12.8

192.4

363

252

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

3.5

192.0

1014

2694

TFP44

NOMESCO Finland

Ablation treatment of typical atrial flutter

+∞

185.0

187

SPAT1097

SPAT

Recording of ECG

2.3

184.6

1951

7960

4273A

ICD-9 Finland

Cardiac dysrhythmias, Atrial fibrillation and flutter

+∞

183.0

185

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

3.1

182.7

1113

3284

FNC10

NOMESCO Finland

Aorto-coronary venous bypass with single distal anastomosis

14.3

182.2

328

204

FGC10

NOMESCO Finland

Annuloplasty of tricuspid valve using prosthetic ring

+∞

182.0

184

C10AA01

ATC

simvastatin; oral

1.7

181.4

5503

33395

205

Kela drug reimbursment

Chronic hypertension

1.9

181.2

3414

17731

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

1556.4

180.8

185

I20.99

ICD-10 Finland

Angina pectoris, unspecified

3.7

180.6

857

2084

FCA50

NOMESCO Finland

Resection and reconstruction of ascending aorta using tube graft

92.7

180.3

210

B01AE07

ATC

dabigatran etexilate; oral

6.9

180.1

482

624

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

7.8

179.2

443

509

PD5AD

NOMESCO Finland

CT of aorta

11.3

177.2

355

280

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

+∞

177.1

179

K77

ICPC

Heart failure

34.9

176.7

241

B01AF01

ATC

rivaroxaban; oral

2.6

175.3

1423

5037

FKC96

NOMESCO Finland

Other repair of mitral valve for insufficiency

+∞

175.1

177

C08CA01

ATC

amlodipine; oral

1.8

174.7

4442

25453

FP4B5

NOMESCO Finland

ECG, prolonged recording (24 h)

34.3

172.2

236

AS4

Physiological pacemaker insertion DDD (R)

527.5

172.2

180

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

4.3

172.0

696

1464

FKD00

NOMESCO Finland

Replacement of mitral valve using mechanical prosthesis

+∞

171.1

173

FWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels

45.8

169.0

218

I35.8

ICD-10 Finland

Other aortic valve disorders

106.4

168.2

193

GD1LA

NOMESCO Finland

33.1

168.0

232

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.0

166.5

2609

12589

AQ1

Conventional electrophysiological examination

227.0

166.2

180

FFM10

NOMESCO Finland

Occlusion or excision of atrial appendage externally with a closing device

+∞

166.2

168

SPAT1263

SPAT

Sampling

1.7

161.3

5186

31673

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

160.2

3633

19948

A02BC02

ATC

pantoprazole; systemic

1.6

160.2

8261

57327

I25.2

ICD-10 Finland

Old myocardial infarction

3.9

159.6

722

1681

FPE30

NOMESCO Finland

Replacement of transvenous cardiac pacemaker pulse generator

488.7

159.4

167

C09DX04

ATC

valsartan and sacubitril; oral

+∞

156.2

158

Z95.4

ICD-10 Finland

Presence of other heart-valve replacement

359.1

154.9

164

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

5.8

154.6

473

731

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

+∞

154.3

156

R04.0

ICD-10 Finland

Epistaxis

3.1

154.2

941

2769

D64.9

ICD-10 Finland

Anaemia, unspecified

2.7

153.2

1176

4013

I44.7

ICD-10 Finland

Left bundle-branch block, unspecified

29.2

151.2

215

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.9

150.6

1045

3349

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

64.6

150.1

183

PC1BD

NOMESCO Finland

Extensive CT of thoracic aorta

30.9

149.7

210

J01CA04

ATC

amoxicillin; systemic

1.7

149.4

10381

77261

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.1

148.8

2007

9070

342

Kela drug reimbursment

Dronedarone

+∞

147.3

149

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

147.1

2756

14119

I97.0

ICD-10 Finland

Postcardiotomy syndrome

77.1

147.1

175

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

2.5

146.6

1320

4924

FCA70

NOMESCO Finland

Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of biological valve prosthesis and tube graft

232.3

146.1

158

M04AA01

ATC

allopurinol; systemic

2.3

145.7

1497

5974

TK800

NOMESCO Finland

Hemodialysis

6.2

145.6

424

615

WX402

NOMESCO Finland

General anaesthesia

2.0

144.8

2357

11466

R55

ICD-10 Finland

Syncope and collapse

2.5

144.0

1249

4560

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

139.2

5291

33412

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.7

138.9

1024

3400

AP1

Catheterization of the left side of the heart

9.8

138.8

298

269

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

+∞

138.4

140

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.1

137.8

1724

7522

WW502

NOMESCO Finland

Autotransfusion

21.1

136.7

213

ZXE00

NOMESCO Finland

One hour or less

1.6

136.3

4841

29982

TFP30

NOMESCO Finland

Cathetric examination for cardiac arrythmia

112.1

134.1

153

R00.1

ICD-10 Finland

Bradycardia, unspecified

7.1

133.9

349

434

Catheterization and pressure measurement of the left side of the heart

10.1

133.5

282

247

C10AX09

ATC

ezetimibe; oral

2.2

132.2

1597

6854

C08DA01

ATC

verapamil; systemic

4.6

131.1

493

961

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

130.3

4847

30283

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

3.1

128.0

792

2346

Catheterization and pressure measurement of the right side of the heart

126.6

127.7

144

FPG30

NOMESCO Finland

Implantation of cardioverter-defibrillator with ventricular electrode

582.9

127.6

133

FC1AC

NOMESCO Finland

Angiography of thoracal aortta

44.0

127.1

165

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.8

126.8

909

2961

I47.9

ICD-10 Finland

Paroxysmal tachycardia, unspecified

17.5

126.5

210

106

C01BD07

ATC

dronedarone; oral

+∞

125.5

127

R02

ICPC

Shortness of breath/dyspnoea

2.2

125.3

1396

5767

I34.8

ICD-10 Finland

Other nonrheumatic mitral valve disorders

1124.1

124.5

128

I42.2

ICD-10 Finland

Other hypertrophic cardiomyopathy

+∞

123.6

125

I49.0

ICD-10 Finland

Ventricular fibrillation and flutter

551.8

120.7

126

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.3

120.5

1235

4895

R00.2

ICD-10 Finland

Palpitations

2.9

119.9

822

2603

FL1AC

NOMESCO Finland

Left cardioangiography

8.5

119.8

279

291

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

5.8

119.3

362

553

R4110

NOMESCO Finland

Physiotherapy

1.7

119.2

3397

19650

FPG32

NOMESCO Finland

Implantation of cardioverter-defibrillator with atrial and ventricular electrodes

538.5

117.8

123

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.5

116.5

1027

3767

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

3.5

115.6

579

1463

FPD10

NOMESCO Finland

Surgical ablation of atrial fibrillation

+∞

114.6

116

Z50.0

ICD-10 Finland

Cardiac rehabilitation

9.8

113.1

243

220

UJF32

NOMESCO Finland

Coloscopy

1.7

112.9

3116

17816

FEB10

NOMESCO Finland

Decompression and drainage of pericardium

137.1

111.6

125

AP3

Catheterization of the right and left side of the heart

111.5

111.3

127

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

3.4

111.3

584

1531

C09AA02

ATC

enalapril; systemic

1.8

111.2

2305

12075

I48.3

ICD-10 Finland

Typical atrial flutter

176.9

110.2

121

N02AX02

ATC

tramadol; systemic, rectal

1.5

109.8

5262

34526

B01AF03

ATC

edoxaban; oral

21.5

109.4

169

I44.0

ICD-10 Finland

Atrioventricular block, first degree

23.3

108.6

164

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.7

108.6

821

2758

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.6

108.1

3446

20450

R50.9

ICD-10 Finland

Fever, unspecified

2.0

106.7

1655

7820

R42

ICD-10 Finland

Dizziness and giddiness

1.8

106.4

2352

12556

AJ1

Reconstruction of the aortic base, eg composite graft, incl. valve saving operation

171.0

106.3

117

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.5

106.0

549

1424

SPAT1301

SPAT

No procedures

1.6

106.0

3648

22061

I42.1

ICD-10 Finland

Obstructive hypertrophic cardiomyopathy

+∞

105.7

107

FKC00

NOMESCO Finland

Repair of mitral valve for insufficiency using ring

+∞

105.7

107

Q25.1

ICD-10 Finland

Coarctation of aorta

41.5

104.5

137

C09CA01

ATC

losartan; oral

1.7

103.9

2946

16908

I38

ICD-10 Finland

Endocarditis, valve unspecified

+∞

103.8

105

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.0

103.3

1495

6872

ZXE40

NOMESCO Finland

More than seven and less than nine hours

4.3

103.2

417

872

H02AB06

ATC

prednisolone; systemic

1.5

102.7

5522

36997

AP2

Catheterization of the right side of the heart

53.5

102.2

128

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.6

102.1

824

2872

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.5

101.3

895

3277

I33.9

ICD-10 Finland

Acute endocarditis, unspecified

463.1

101.1

106

ZSF00

NOMESCO Finland

Procedure related to previous procedure classified in chapter F

162.2

100.5

111

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

458.7

100.1

105

C08DB01

ATC

diltiazem; oral

3.4

99.7

535

1426

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

5.0

99.6

345

616

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

6.1

99.3

289

419

WZC30

NOMESCO Finland

Teaching

1.9

99.0

1777

8834

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

97.2

4638

30162

TFP47

NOMESCO Finland

Ablation or modification of the AV-node

+∞

96.8

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

3.1

96.6

588

1717

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

4.0

96.5

421

945

Z2221

NOMESCO Finland

Medical doctor

1.6

95.5

3180

18971

I20.09

ICD-10 Finland

Unstable angina

3.0

95.0

605

1821

I37.0

ICD-10 Finland

Pulmonary valve stenosis

+∞

93.9

N18.8

ICD-10 Finland

Other chronic renal failure

4.6

93.7

351

681

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.2

92.7

1011

4107

TFP32

NOMESCO Finland

Cathetric treatmen of cardiac arrythmia

831.2

91.9

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

5.4

91.3

293

480

C07AB03

ATC

atenolol; systemic

2.8

91.1

638

2041

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.7

90.9

2512

14238

FM1CG

NOMESCO Finland

Extensive examination of hear with high intensity magnet

32.3

90.4

125

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.6

90.1

725

2519

FC1BC

NOMESCO Finland

Extensive angiography of thoracal aortta

57.2

89.7

111

R53

ICD-10 Finland

Malaise and fatigue

1.7

89.6

1980

10511

ZX120

NOMESCO Finland

Intravenous

2.1

89.2

1150

5030

AQ2

Electrophysiological electroanatomical examination

+∞

88.9

AA1

Conventional CABG

6.5

88.9

247

337

FN1CD

NOMESCO Finland

Very extensive CT of coronary arteries

8.8

88.2

200

C07AG02

ATC

carvedilol; oral

2.6

88.0

705

2441

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

87.9

4318

28091

I31.3

ICD-10 Finland

Pericardial effusion (noninflammatory)

+∞

87.9

I48.4

ICD-10 Finland

Atypical atrial flutter

+∞

87.9

I37.1

ICD-10 Finland

Pulmonary valve insufficiency

+∞

87.9

XF600

NOMESCO Finland

Bloodpressure measurement

2.5

87.8

745

2666

FPG96

NOMESCO Finland

Other implantation of permanent cardioverter-defibrillator

+∞

86.9

M10.9

ICD-10 Finland

Gout, unspecified

2.6

86.8

709

2484

K04

ICPC

Palpitations/awareness of heart

3.0

86.6

535

1577

Q23.0

ICD-10 Finland

Congenital stenosis of aortic valve

205.8

86.5

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.6

86.3

419

1031

XF622

NOMESCO Finland

Measurement of minute volume of heart

22.8

85.8

130

K05

ICPC

Irregular heartbeat other

4.6

85.1

314

600

SPAT1325

SPAT

Vaccination

1.5

84.9

3755

23837

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

4.0

84.3

366

818

C08CA02

ATC

felodipine; oral

2.1

84.3

1030

4399

Aortic Valve Replacement (AVR)

760.6

84.0

TFP40

NOMESCO Finland

Ablation treatment for a-v node re-entry activation

+∞

84.0

J01FF01

ATC

clindamycin; systemic

1.5

83.8

3242

19949

A46

ICD-10 Finland

Erysipelas

1.8

83.6

1527

7607

I35

ICD-10 Finland

Nonrheumatic aortic valve disorders

161.1

83.3

FPD00

NOMESCO Finland

Maze procedure for atrial fibrillation

+∞

83.0

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

7.5

82.7

208

246

K29

ICPC

Cardiovascular sympt/complt other

3.1

82.4

496

1436

FPE96

NOMESCO Finland

Other implantation or replacement of transvenous cardiac pacemaker

+∞

82.0

AR6

Catheter ablation of arrhythmia, target: atrial fibrillation

+∞

82.0

4240B

ICD-9 Finland

Other diseases of endocardium, Mitral valve disorders[PROLAPSUS VALVULAE MITRALIS (SYNDROMA BARLOW)]

+∞

82.0

C10AA07

ATC

rosuvastatin; oral

1.5

81.3

3091

18920

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.6

80.6

2688

15935

SPAT1260

SPAT

Consultation of another employee

1.7

80.6

2073

11473

A12BA01

ATC

potassium chloride; oral

3.4

79.9

421

1106

PD5CG

NOMESCO Finland

Extensive MRI examination of thoracal and abdominal aortta with high intensity magnet

20.3

79.7

125

Z49.1

ICD-10 Finland

Extracorporeal dialysis

6.2

79.4

226

319

1CX08

NOMESCO Finland

99.6

79.0

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

6.6

78.9

216

289

A11CC03

ATC

alfacalcidol; systemic

4.1

78.7

325

694

I30.9

ICD-10 Finland

Acute pericarditis, unspecified

698.9

77.2

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

9.4

77.0

168

157

XF614

NOMESCO Finland

Measurement of pulmonary artery pressure

55.4

76.5

TFC99

NOMESCO Finland

Catheterisation of heart with other procedure

47.2

76.0

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.9

75.9

1261

6064

SPAT1310

SPAT

Counselling related to known health issue

1.5

75.7

3700

23875

Q21.09

ICD-10 Finland

Ventricular septal defect NOS

26.1

75.5

110

Q23.10

ICD-10 Finland

Congenital insufficiency of aortic valve

237.1

75.2

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

3.2

74.8

432

1214

SPAT1153

SPAT

Removal of sutures

1.5

73.8

3847

25124

A41.9

ICD-10 Finland

Sepsis, unspecified

3.2

73.4

425

1197

Q21.10

ICD-10 Finland

Persistent ostium secundum

12.0

73.3

141

103

Q21.30

ICD-10 Finland

Tetralogy of Fallot

231.0

73.2

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

72.9

3670

23784

5273

FHL

Repair with flap prosthesis or graft

+∞

72.1

S18

ICPC

Laceration/cut

1.4

71.8

4956

34116

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.6

71.8

2450

14553

J01DB01

ATC

cefalexin; oral

1.4

71.7

10188

79669

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

3.2

71.7

412

1152

PD5CD

NOMESCO Finland

Very extensive CT angiography of aorta

11.6

71.6

140

106

L04AA06

ATC

mycophenolic acid; systemic

4.0

71.4

307

681

C08CA13

ATC

lercanidipine; oral

1.8

71.2

1461

7535

I71.00

ICD-10 Finland

Dissecting aneurysm of aorta (ruptured) [any part]

16.4

71.2

120

FM1DE

SPAT

21.7

71.0

109

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

70.6

4988

34451

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.4

69.8

3943

26100

5253

FHL

Cardiac lung machine

18.0

69.3

113

AD1

TVP

+∞

69.1

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

3.9

69.0

300

672

I20.90

ICD-10 Finland

Angina pectoris, unspecified

3.3

68.8

372

997

Electrophysiological Special Examination

66.1

68.7

4240A

ICD-9 Finland

Other diseases of endocardium, Mitral valve disorders[INSUFFICIENTIA VALVULAE MITRALIS (NON RHEUMATICA)]

+∞

68.1

3A064

NOMESCO Finland

25.0

68.0

100

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.6

67.5

2311

13709

FNC20

NOMESCO Finland

Aorto-coronary venous bypass with two distal anastomoses

4.8

67.5

239

438

Q21.00

ICD-10 Finland

Multiple ventricular septal defect

30.5

67.3

J01MA12

ATC

levofloxacin; systemic

1.6

67.1

2007

11511

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.4

67.1

347

899

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

4.7

66.5

242

457

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

66.4

4309

29212

C10AA03

ATC

pravastatin; oral

2.1

66.4

793

3343

AR5

Catheter ablation of arrhythmia, target: atrial flutter

602.0

66.3

Mitral valve plasty

+∞

66.2

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

3.8

65.9

300

700

GAE10

NOMESCO Finland

Closure of previous incision of chest wall

75.9

65.8

I34

ICD-10 Finland

Nonrheumatic mitral valve disorders

206.9

65.5

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.2

65.3

369

1021

SPAT1104

SPAT

Monitoring of emergency patient

2.2

65.1

721

2937

127

Kela drug reimbursment

Transplant complication

4.0

64.9

276

606

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

7.5

64.3

160

187

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

2.7

63.9

459

1490

Catheter ablation of arrhythmia

295.1

63.9

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

2.3

63.8

636

2467

G45.3

ICD-10 Finland

Amaurosis fugax

4.2

63.7

260

550

A12AA04

ATC

calcium carbonate; oral

4.8

63.6

226

416

FPH10

NOMESCO Finland

Open removal of transvenous cardiac pacemaker or cardioverter-defibrillator

575.7

63.4

I42.8

ICD-10 Finland

Other cardiomyopathies

575.7

63.4

AC1

MVR mechanical

+∞

63.2

K22

ICPC

Risk factor cardiovascular disease

2.3

63.1

622

2398

I51.4

ICD-10 Finland

Myocarditis, unspecified

124.1

63.1

R07.3

ICD-10 Finland

Other chest pain

1.9

63.0

1014

4809

SPAT1254

SPAT

Administration of medicine

1.7

62.9

1381

7255

SPAT1312

SPAT

General health counselling

1.4

62.8

3628

24011

AS2

Ventricular pacemaker insertion VVI (R)

566.9

62.4

I34.02

ICD-10 Finland

Mitralysis insufficiency caused by ischemia

+∞

62.2

Congenital heart failure surgery

43.7

61.9

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.3

61.7

623

2430

SPAT1255

SPAT

Intravenous administration of medicine

2.2

61.6

714

2969

Q21.08

ICD-10 Finland

Other specifed ventricular septal defect

15.9

61.6

105

GD1AD

NOMESCO Finland

Thorax CT examination

2.5

61.5

534

1931

C02EA02

ATC

2.8

61.4

424

1343

I45.9

ICD-10 Finland

Conduction disorder, unspecified

34.5

61.3

FM2CE

NOMESCO Finland

8.7

60.8

138

139

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.3

60.7

587

2241

S97

ICPC

Chronic ulcer skin

2.5

60.4

527

1910

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

59.5

1854

10714

AJ2

Reconstruction of the ascending aorta

53.9

59.5

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.9

59.2

1012

4896

FXZ00

NOMESCO Finland

Off-pump cardiac operation

11.1

58.9

117

H25.1

ICD-10 Finland

Senile nuclear cataract

1.5

58.9

2134

12788

Q87.4

ICD-10 Finland

Marfan syndrome

37.9

58.7

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.5

58.7

488

1722

FN1BB

NOMESCO Finland

Contrast angiography of heart and/or coronary arteries after bypass surgery

8.2

58.4

137

146

N19

ICD-10 Finland

Unspecified kidney failure

3.4

58.4

301

778

B03XA02

ATC

darbepoetin alfa; parenteral

4.1

58.4

244

528

FPE40

NOMESCO Finland

Replacement of transvenous cardiac pacemaker electrode

+∞

58.3

42792

ICD-8 Finland

Symptomatic heart disease, Fibrillatio auricularis

+∞

58.3

Q22.1

ICD-10 Finland

Congenital pulmonary valve stenosis

35.9

58.1

A28

ICPC

Limited function/disability NOS

1.8

58.1

1169

5973

211

AVR mechanical

522.9

57.5

Z94.1

ICD-10 Finland

Heart transplant status

34.1

57.4

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.4

57.4

519

1916

TFP45

NOMESCO Finland

Ablation treatment of non-typical atrial flutter

+∞

57.3

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.9

57.2

381

1180

C02AC05

ATC

moxonidine; oral

2.4

56.8

498

1809

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

5.7

56.7

173

268

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

56.6

3239

21314

A41.8

ICD-10 Finland

Other specified sepsis

4.5

56.6

213

417

C03AA03

ATC

hydrochlorothiazide; oral

1.8

56.6

1004

4920

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

18.5

56.5

FM1CD

NOMESCO Finland

Very extensive CT of heart

30.0

56.5

42798

ICD-8 Finland

Symptomatic heart disease, Alia arrhytmia definita

+∞

56.3

TFJ02

NOMESCO Finland

Muscle biopsy of heart

263.9

56.1

XF405

NOMESCO Finland

Symptom ECG

10.5

55.4

113

A40.8

ICD-10 Finland

Other streptococcal sepsis

7.2

55.2

141

172

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

55.0

1565

8821

XF409

NOMESCO Finland

Other special ECG

21.6

54.9

FCA75

NOMESCO Finland

Valve-sparing repair of aortic root (David, Yacoub)

133.2

54.6

TFC20

NOMESCO Finland

Catheterisation of both sides of heart

133.2

54.6

FPJ04

NOMESCO Finland

Revision of pacemaker generator with atrial and ventricular electrodes

+∞

54.3

4241A

ICD-9 Finland

Other diseases of endocardium, Aortic valve disorders[INSUFFICIENTIA VALVULAE AORTAE (NON RHEUMATICA)]

+∞

54.3

K92.1

ICD-10 Finland

Melaena

2.3

54.0

516

1957

WX882

NOMESCO Finland

High dependency care

2.8

54.0

367

1151

C09CA06

ATC

candesartan; oral

1.5

53.9

2399

15003

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

2.6

53.7

429

1482

WX720

NOMESCO Finland

Own respiration

2.5

53.6

464

1673

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

53.5

1810

10648

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.5

53.5

458

1643

C08CA05

ATC

nifedipine; systemic

2.1

53.2

641

2709

A02BC01

ATC

omeprazole; systemic

1.4

53.1

2965

19385

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.2

52.9

595

2440

O99.4

ICD-10 Finland

Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium

19.6

52.6

I71.09

ICD-10 Finland

Aortic dissection [regardless of location]

12.4

52.5

R60.0

ICD-10 Finland

Localized oedema

1.8

52.5

1043

5302

I25

ICD-10 Finland

Chronic ischaemic heart disease

2.6

52.4

410

1399

WX002

NOMESCO Finland

Sedation and analgesia

1.5

52.3

2196

13554

FPD96

NOMESCO Finland

Other operation for atrial fibrillation

+∞

52.3

FFM30

NOMESCO Finland

Occlusion of atrial appendage internally by internal suture ligation

+∞

52.3

I36.0

ICD-10 Finland

Nonrheumatic tricuspid (valve) stenosis

+∞

52.3

I20.00

ICD-10 Finland

Unstable angina

3.3

52.3

287

779

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

52.1

1350

7414

PD5BG

NOMESCO Finland

MRI examination of thoracal and abdominal aortta with high intensity magnet

31.5

52.1

R31

ICD-10 Finland

Unspecified haematuria

1.8

51.7

932

4587

TK810

NOMESCO Finland

Hemofiltration

8.3

51.7

120

126

I40.9

ICD-10 Finland

Acute myocarditis, unspecified

103.1

51.6

FM1AD

NOMESCO Finland

CT of heart

41.8

51.6

742

NOMESCO Finland

23.2

51.5

FKC10

NOMESCO Finland

Suture of cleft mitral leaflet

+∞

51.3

AH3

Treatment of arrhythmias, eg atrial fibrillation, in conjunction with other cardiac surgery

+∞

51.3

C09CA03

ATC

valsartan; oral

1.8

51.3

985

4948

V03AE02

ATC

sevelamer; oral

9.5

51.2

110

101

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

51.1

2940

19302

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

2.4

51.1

481

1813

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.9

51.1

811

3819

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.0

50.8

697

3108

4276B

ICD-9 Finland

Cardiac dysrhythmias, Premature beats[EXTRASYSTOLIA VENTRICULARIS]

+∞

50.4

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.9

50.0

324

985

FPW96

NOMESCO Finland

Other operation for arhythmia or disturbance of impulse propagation

17.7

49.6

I20.01

ICD-10 Finland

Unstable angina

3.1

48.8

285

809

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

48.4

758

3548

Z3231

NOMESCO Finland

Registered nurse

1.4

48.4

2934

19420

4241B

ICD-9 Finland

Other diseases of endocardium, Aortic valve disorders[STENOSIS VALVULAE AORTAE (NON RHEUMATICA)]

+∞

48.4

I36.9

ICD-10 Finland

Nonrheumatic tricuspid valve disorder, unspecified

+∞

48.4

L28

ICPC

Limited function/disability (L)

1.6

48.4

1391

7849

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

48.3

1336

7462

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.7

48.3

1028

5330

SPAT1081

SPAT

Cardiorespiratory global assessment

2.1

47.7

569

2392

V03AE01

ATC

polystyrene sulfonate; oral

5.2

47.7

157

267

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.0

47.6

622

2719

FNC30

NOMESCO Finland

Aorto-coronary venous bypass with three distal anastomoses

4.8

47.4

168

310

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

8.6

47.0

107

109

TKC20

NOMESCO Finland

Catheterisation of bladder

2.0

46.8

651

2916

FPH96

NOMESCO Finland

Other removal of cardiac pacemaker or cardioverter-defibrillator

24.1

46.7

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.9

46.4

759

3607

H53.1

ICD-10 Finland

Subjective visual disturbances

2.0

46.3

678

3098

C01BA03

ATC

disopyramide; systemic

23.2

46.2

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

5.0

46.0

157

278

XF620

NOMESCO Finland

Examination of circulation with color method

8.7

46.0

104

105

WX870

NOMESCO Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3021960) Folate [Moles/volume] in Serum or Plasma

6881

32062

1.79

314.71

1.7

1.5

nmol/l

20.1

20.8

2.58

5849

26815

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1961

5586

2.70

313.81

5.7

4.3

mmol/l

23.9

24.0

0.45

1722

5041

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1881

5283

2.73

309.04

3.9

2.6

1.2

1.3

2.16

1873

5254

(3013512) EKG study

8668

40005

1.90

307.65

6.1

3.2

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2491

5124

3.84

307.65

1.8

1.6

g/l

1.4

1.6

14.32

2012

4356

(3018677) aPTT in Platelet poor plasma by Coagulation assay

7306

18651

3.66

307.65

2.8

1.9

30.8

29.0

81.94

7125

18131

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

7014

22808

2.75

307.65

5.4

2.8

ng/l

1300.0

460.4

8.18

6365

17387

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2681

7532

2.80

307.65

10.2

6.7

mmol/l

24.7

0.07

2660

7469

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1479

3241

3.48

307.65

3.4

2.6

g/l

3.3

3.6

7.41

1427

3108

(3014576) Chloride [Moles/volume] in Serum or Plasma

4957

15769

2.63

307.65

9.2

6.3

mmol/l

104.8

104.4

4.98

4856

15447

(3027456) Digoxin [Moles/volume] in Serum or Plasma

1406

222

49.04

307.65

3.3

2.0

nmol/l

0.8

0.20

1111

100

(3038071) Oxygen [Partial pressure] in Mixed venous blood

357

144

18.36

307.65

8.6

8.1

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

8639

30904

2.61

307.65

2.7

2.1

mg/l

3.3

2.8

49.80

7556

25860

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2912

7508

3.08

307.65

11.2

8.0

1.4

1.3

1.04

2897

7459

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

5371

14526

3.18

307.65

3.9

4.5

u/l

269.0

239.7

25.93

5099

13697

(3031040) Bacteria [#/volume] in Urine by Automated count

15784

91122

1.75

307.65

5.4

4.2

e6/l

740.7

1520.3

1.55

217

1311

(3019198) Lymphocytes [#/volume] in Blood

12924

68559

1.80

307.65

6.8

5.9

e9/l

1.8

2.0

11.93

11430

59431

(3020630) Protein [Mass/volume] in Serum or Plasma

3207

10763

2.35

307.65

2.5

2.7

g/l

65.6

67.0

18.44

2932

9717

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1837

4672

3.02

307.65

2.2

1.9

ug/l

1.8

2.3

1.18

1607

4115

(3021447) Carbon dioxide [Partial pressure] in Venous blood

3597

11086

2.61

307.65

5.2

3.7

kpa

5.8

2.59

3500

10774

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

2160

2949

5.77

307.65

5.0

2.6

u/ml

0.3

0.84

1386

1565

(3019309) Folate [Moles/volume] in Red Blood Cells

6009

25868

1.93

307.65

1.9

1.7

nmol/l

1259.6

1130.8

18.21

4593

18992

(3022217) INR in Platelet poor plasma by Coagulation assay

6593

12252

5.02

307.65

44.0

9.2

inr

1.9

1.1

107.71

649

2156

(3001122) Ferritin [Mass/volume] in Serum or Plasma

11167

50574

2.13

307.65

3.7

2.6

ug/l

167.6

148.1

1.79

10259

46058

(3000991) Gas panel - Venous blood

3490

10025

2.80

307.65

11.1

7.5

—

(3006315) Basophils [#/volume] in Blood

12799

66985

1.83

307.65

6.8

5.8

e9/l

0.0

2.23

11176

57007

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

15028

30174

7.89

307.65

4.5

1.8

ng/l

1872.9

605.0

149.54

13828

24454

(3019060) Gas panel - Arterial blood

3011

7480

3.21

307.65

6.8

4.4

—

(3013115) Eosinophils [#/volume] in Blood

13093

69159

1.83

307.65

7.0

6.0

e9/l

0.2

1.39

11536

59694

(3023368) Bacteria identified in Blood by Culture

9185

35129

2.46

307.65

5.7

3.9

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

4895

13586

3.04

307.65

9.9

6.4

kpa

5.1

2.02

4694

12973

(3032080) INR in Blood by Coagulation assay

14893

50739

3.94

307.65

21.0

4.3

inr

1.6

1.1

257.89

4301

13757

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2198

6329

2.69

307.65

12.4

8.2

mmol/l

24.4

24.2

1.12

2040

5926

(3013826) Glucose [Moles/volume] in Serum or Plasma

16319

79545

2.51

307.65

7.3

4.1

mmol/l

6.8

1.45

15612

74008

(3012544) pH of Venous blood

3917

11436

2.79

307.65

5.4

3.6

7.4

0.11

(3020779) Urea [Moles/volume] in Serum or Plasma

4354

10251

3.56

307.65

9.6

6.3

mmol/l

11.0

8.9

55.61

4162

9732

(3004119) Hemoglobin [Mass/volume] in Venous blood

2563

7025

2.86

307.65

5.0

2.9

g/l

121.1

129.5

53.05

2486

6878

(3018418) pH of Serum or Plasma

8489

40515

1.81

307.65

5.4

3.8

7.4

1.90

1883

7384

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

3929

13331

2.37

307.65

1.9

1.6

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

5949

19763

2.59

307.65

4.0

3.5

mmol/l

0.8

19.33

5575

18253

(3002173) Hemoglobin [Mass/volume] in Arterial blood

4212

11216

3.11

307.65

10.7

7.1

g/l

115.4

122.4

76.52

4097

10779

(3020891) Body temperature

1804

4609

3.01

307.65

6.3

4.3

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

18485

108525

2.01

307.65

9.2

7.3

u/l

81.3

79.5

4.22

17526

101356

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2787

7316

3.01

307.65

10.1

6.2

mmol/l

24.6

24.7

0.64

2633

6761

(3002032) Base excess in Venous blood by calculation

3604

11070

2.62

307.65

5.2

3.7

mmol/l

1.7

0.01

2977

8932

(3024928) Oxygen saturation in Venous blood

1136

2060

4.18

307.65

5.1

3.1

—

(3023520) Reticulocytes [#/volume] in Blood

3802

10702

2.89

307.65

2.9

2.6

e9/l

72.0

67.3

9.56

2946

8044

(42870588) Differential panel, method unspecified - Blood

9420

46281

1.79

307.65

6.7

5.9

—

(3019069) Monocytes/100 leukocytes in Blood

11760

63228

1.69

307.65

7.4

6.3

9.1

8.7

32.39

11049

58657

(3003396) Base excess in Arterial blood by calculation

4892

13551

3.05

307.65

9.9

6.4

mmol/l

1.1

0.9

3.23

4005

10646

(3044889) 12 lead EKG panel

17237

97717

1.99

307.65

6.5

3.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2475

6589

2.94

307.65

13.9

8.1

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

5865

15544

3.31

307.65

3.4

2.2

20.8

23.7

41.33

5017

13095

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

14455

70645

2.22

307.65

6.7

6.4

umol/l

13.6

11.4

49.18

13747

66754

(3014007) Fractional oxyhemoglobin in Arterial blood

2954

7522

3.13

307.65

11.4

8.1

94.0

94.3

1.23

2945

7502

(3003458) Phosphate [Moles/volume] in Serum or Plasma

4821

16379

2.43

307.65

8.4

5.2

mmol/l

1.1

1.0

42.11

4502

15192

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

6252

26514

1.97

307.65

2.2

1.6

mg/l

1.3

0.19

4824

20613

(3027801) Oxygen [Partial pressure] in Arterial blood

4890

13578

3.04

307.65

9.9

6.4

kpa

12.5

12.9

4.09

4684

12960

(3013650) Neutrophils [#/volume] in Blood by Automated count

14159

78262

1.77

307.65

9.5

9.4

e9/l

4.3

4.1

32.87

12450

67729

(3022948) Iron [Moles/volume] in Serum or Plasma

6443

18234

3.15

307.65

3.4

2.2

umol/l

11.8

13.5

55.85

6028

16712

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

14195

69208

2.19

307.65

10.1

6.0

mmol/l

1.2

201.68

11869

58030

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

12833

64080

1.98

307.65

5.0

3.8

—

(3024354) Oxygen [Partial pressure] in Venous blood

2976

9225

2.55

307.65

4.3

3.2

kpa

4.6

0.23

2887

8929

(3004789) Transferrin [Mass/volume] in Serum or Plasma

6081

16729

3.21

307.65

3.4

2.2

g/l

2.3

0.06

5711

15291

(3022096) Basophils/100 leukocytes in Blood

11449

61004

1.70

307.65

7.1

6.1

0.7

4.22

10728

56405

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

7478

33010

1.94

307.65

2.9

2.3

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

9856

40589

2.30

307.65

2.5

2.0

u/l

241.0

214.6

2.39

9262

37726

(3042936) Bacteria identified in Isolate by Culture

4708

18232

2.10

307.65

2.3

1.9

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

13202

62707

2.17

307.65

9.2

5.3

mmol/l

1.2

204.71

12057

56001

(3016502) Oxygen saturation in Arterial blood

4590

12006

3.21

307.65

10.2

6.8

95.8

96.0

0.90

4448

11567

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2908

7458

3.10

307.65

11.5

8.1

0.7

3.88

2898

7410

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

407

161

18.76

307.65

9.0

7.7

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

12296

59720

2.02

307.65

6.0

4.6

g/l

34.4

35.6

90.07

11393

55063

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

12333

47406

2.82

307.65

5.2

2.7

ng/l

66.2

59.6

0.23

9877

32689

(3027945) Reticulocytes/100 erythrocytes in Blood

5021

14224

2.99

307.65

2.7

2.5

1.8

1.7

15.97

4522

12450

(3001604) Monocytes [#/volume] in Blood

12731

66634

1.83

307.65

6.7

5.8

e9/l

0.6

23.71

11105

56686

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

5576

19653

2.39

307.65

2.0

1.7

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

5075

8011

5.58

307.65

3.9

1.9

ng/l

286.0

84.6

114.43

4807

7102

(3044640) Blood type and Crossmatch panel - Blood

9220

43290

1.89

307.65

3.1

2.3

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

5239

8807

5.26

307.65

2.7

1.9

ug/l

12.9

5.9

58.20

4800

7453

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

3937

13328

2.38

307.65

2.0

1.6

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

3463

10391

2.67

307.65

9.7

6.2

mmol/l

1.3

1.01

3354

9993

(3006504) Eosinophils/100 leukocytes in Blood

11711

62851

1.70

307.65

7.1

6.0

2.8

2.9

4.35

10953

58054

(3018405) Lactate [Moles/volume] in Arterial blood

1581

4052

2.98

306.41

5.6

3.7

mmol/l

1.3

1.4

0.15

1558

3979

(3013707) Erythrocyte sedimentation rate by Westergren method

17099

102720

1.72

301.04

5.1

3.9

mm/h

15.3

12.1

104.31

15771

93917

(3002030) Lymphocytes/100 leukocytes in Blood

11877

64879

1.66

300.30

7.3

6.1

24.7

28.2

196.51

11111

59827

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1837

5188

2.72

298.34

3.9

2.6

0.7

3.10

1779

4935

(3018010) Neutrophils/100 leukocytes in Blood

11713

63896

1.65

296.20

7.0

5.9

59.7

56.7

122.44

10972

59225

(3006576) Bicarbonate [Moles/volume] in Blood

390

278

10.40

295.80

8.1

4.9

mmol/l

25.2

24.9

0.63

339

261

(3043409) Potassium [Moles/volume] in Arterial blood

1408

3460

3.09

292.76

5.9

3.9

mmol/l

4.0

3.8

24.96

1337

3265

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

21457

138760

2.09

289.95

24.3

12.4

mg/l

27.7

25.3

19.50

18733

107629

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

8388

42401

1.68

279.82

3.4

3.3

u/l

36.0

34.2

1.16

7984

39964

(3003434) Protein [Mass/volume] in Pleural fluid

759

1242

4.58

278.83

1.6

1.3

g/l

28.0

38.0

69.44

669

1158

(3026008) Bacteria identified in Urine by Culture

8078

40577

1.68

274.77

3.5

3.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

268

107

18.49

272.43

8.1

7.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

3468

13524

2.02

267.77

4.3

3.0

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

8356

42574

1.66

267.46

2.8

2.5

u/l

59.2

59.8

0.33

7678

38835

(3026493) Urate [Moles/volume] in Serum or Plasma

7234

35628

1.69

262.27

3.3

2.5

umol/l

3721.9

5196.7

2.38

6195

30565

(3033658) Prothrombin time (PT) actual/Normal

7082

34906

1.68

254.43

5.4

3.7

76.0

93.8

307.65

6924

34065

(3000850) Epithelial cells [#/volume] in Urine

6102

28912

1.72

253.31

3.1

2.5

e6/l

4.7

5.1

1.60

5419

25054

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1355

3548

2.90

251.83

4.2

2.2

85.9

91.5

13.86

1299

3300

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

10698

58578

1.60

251.39

2.2

1.9

pmol/l

94.8

95.6

0.91

5732

29564

(3037467) Urinalysis macro (dipstick) panel - Urine

15957

96068

1.62

251.29

5.2

4.1

—

(3027315) Oxygen [Partial pressure] in Blood

1093

2536

3.25

248.82

5.2

3.4

kpa

8.3

8.7

5.93

1072

2475

(3004588) Protein electrophoresis panel - Serum or Plasma

2543

9113

2.16

243.74

2.4

—

(3010421) pH of Blood

1186

2946

3.04

241.34

5.2

3.3

7.4

0.09

1056

2467

(3013290) Carbon dioxide [Partial pressure] in Blood

1076

2527

3.21

240.14

5.2

3.3

kpa

5.0

0.65

1055

2467

(3036489) Thrombin time

1518

4335

2.66

239.87

3.0

2.0

23.0

21.2

12.31

1373

3800

(3012501) Base excess in Blood by calculation

1075

2527

3.20

239.55

5.2

3.3

mmol/l

2.6

2.4

1.37

744

1700

(3007853) Bacteria identified in Skin by Aerobe culture

3630

14961

1.91

236.54

2.0

1.7

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

1847

5849

2.41

235.90

4.5

2.9

mmol/l

25.1

25.2

0.22

1791

5688

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1145

2829

3.05

235.01

1.7

1.6

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

782

1501

3.90

234.71

7.8

5.6

mg/l

11.9

11.6

1.12

719

1386

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2312

8110

2.20

233.13

5.1

3.5

kpa

5.1

0.80

2139

7474

(3009343) pH of Capillary blood

2290

8004

2.20

232.94

5.1

3.5

7.4

1.79

372

901

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2226

7714

2.22

231.10

5.1

3.5

mmol/l

2.1

1.5

10.22

1656

5730

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2465

8905

2.14

230.85

1.8

1.6

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1222

3186

2.90

228.44

3.1

2.5

196.9

191.4

1.25

1174

3025

(3030467) Casts [#/volume] in Urine by Automated count

7612

39067

1.62

227.86

3.8

3.0

e6/l

0.5

0.4

3.90

6009

28981

(3023199) Leukocytes [#/volume] in Pleural fluid

661

1143

4.31

226.92

1.6

1.4

e6/l

2545.8

3511.2

0.53

491

846

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2006

6706

2.29

226.57

1.5

1.4

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

16482

101218

1.59

223.66

4.3

3.8

pmol/l

15.2

14.8

76.13

14769

90267

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2588

9660

2.07

222.18

5.0

3.6

ng/l

114.5

80.7

37.72

2226

8247

(3002582) Erythrocytes [#/volume] in Urine

8094

42511

1.59

217.70

3.9

3.1

e6/l

110.5

75.4

0.80

6473

32185

(36304419) Bacteria [Presence] in Urine

7333

37664

1.60

216.30

3.7

3.0

—

(40767503) Oxygen content in Capillary blood by calculation

995

2408

3.10

211.10

2.9

2.2

15.6

16.8

11.24

507

1291

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

19482

125275

1.68

211.07

5.3

4.5

mu/l

2.1

1.05

17650

112337

(3028308) Erythrocytes [#/volume] in Pleural fluid

608

1042

4.35

210.96

1.6

1.4

e6/l

49335.6

57932.1

0.36

376

645

(3018095) Leukocytes [#/volume] in Urine

9091

49310

1.55

210.66

4.4

3.6

e6/l

102.8

101.2

0.05

6890

34600

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1639

5182

2.40

209.29

7.8

4.3

1.7

1.6

3.41

1549

4870

(3012441) Differential panel - Pleural fluid

585

980

4.44

208.67

1.6

1.4

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1378

4016

2.60

208.53

3.2

3.5

mg/l

45.5

41.8

0.43

1089

3304

(3034860) Kappa light chains.free [Mass/volume] in Serum

1380

4027

2.59

208.30

3.2

3.5

mg/l

56.7

58.9

0.06

1093

3307

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1347

3892

2.62

207.33

3.1

3.4

ratio

10.3

3.4

0.63

325

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1416

4210

2.55

205.76

2.8

2.1

ug/l

512.5

604.6

0.59

1343

3933

(3019550) Sodium [Moles/volume] in Serum or Plasma

22040

147244

1.98

205.11

31.0

13.9

mmol/l

139.3

139.7

88.00

21663

142841

(3026782) Osmolality of Urine

5594

27211

1.65

203.01

3.3

2.6

mosm/kgh2o

524.4

563.8

35.18

4808

22922

(1616796) Gas panel - Central venous blood

1002

2509

3.00

200.60

4.9

3.0

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

1602

5109

2.38

200.48

7.9

4.3

0.9

0.99

1510

4797

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1671

5457

2.33

198.23

5.0

3.4

49.4

47.3

2.77

1655

5399

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

194

18.54

197.61

7.7

4.2

68.2

58.7

1.08

167

(3023103) Potassium [Moles/volume] in Serum or Plasma

22048

147677

1.96

196.26

31.3

14.0

mmol/l

4.0

158.10

21647

143003

(3035350) Ketones [Presence] in Urine by Test strip

11622

67252

1.50

193.77

4.6

3.5

estimate

0.0

0.25

2423

12032

(3047181) Lactate [Moles/volume] in Blood

1279

3765

2.56

189.32

9.5

5.1

mmol/l

1.3

0.31

1148

3294

(3015736) pH of Urine

9366

52036

1.51

187.96

4.3

3.3

5.8

5.7

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1246

3636

2.58

187.68

1.9

1.6

—

(3021589) Normoblasts [#/volume] in Blood

10672

61030

1.49

185.45

13.9

9.0

e9/l

0.0

0.00

8956

49782

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

2676

10741

1.92

185.41

2.9

2.6

ml/min/173m2

56.6

67.1

33.93

1196

4034

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2021

7339

2.10

184.88

1.8

1.6

—

(3039000) Anion gap in Blood

1013

2681

2.84

183.75

10.4

6.0

mmol/l

10.9

11.1

1.18

935

2409

(3018572) Chloride [Moles/volume] in Blood

1013

2682

2.84

183.62

10.4

6.0

mmol/l

105.3

105.1

0.49

935

2410

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1023

2737

2.81

181.90

1.6

—

(3028271) Lactate [Moles/volume] in Capillary blood

771

1750

3.29

181.10

2.0

1.7

mmol/l

1.7

0.13

752

1709

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

998

2656

2.82

179.15

1.6

1.7

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

506

858

4.38

177.78

1.4

1.3

u/l

250.8

689.3

7.61

478

810

(3009261) Glucose [Presence] in Urine by Test strip

11661

68425

1.47

173.95

4.7

3.5

estimate

0.0

0.75

2365

11979

(40760888) Immunoglobulin light chains.free panel - Serum

1062

2974

2.68

173.22

3.2

3.6

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

908

2343

2.90

172.22

1.5

1.6

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

8576

47461

1.49

170.61

3.4

3.5

mmol/l

2.3

2.4

24.35

7316

40878

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1354

4306

2.37

169.80

2.7

—

(3045788) Cell count panel - Pleural fluid

500

877

4.23

168.46

1.6

1.4

—

(3021601) Nitrite [Presence] in Urine by Test strip

11510

67648

1.46

167.98

6.0

4.7

estimate

0.0

0.07

2437

12277

(3029937) Albumin [Presence] in Urine by Test strip

6848

36361

1.52

164.71

5.1

3.9

estimate

0.0

0.78

2262

11814

(3022806) Fractional oxyhemoglobin in Capillary blood

627

1326

3.52

163.86

1.9

1.7

89.2

89.7

1.20

616

1307

(40768806) Pleura Pathology biopsy report

547

1051

3.87

163.66

1.6

1.5

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1025

2949

2.61

158.39

3.7

2.8

mmol/l

24.6

0.00

927

2599

(3036782) Glucose [Moles/volume] in Pleural fluid

485

876

4.11

157.42

1.5

1.3

mmol/l

6.8

5.6

12.70

458

792

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1538

5345

2.18

156.39

1.5

1.6

u/ml

14.8

17.3

0.22

161

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

3885

18255

1.66

155.91

10.7

5.8

—

(40761511) CBC panel - Blood by Automated count

21540

145006

1.74

155.24

24.4

11.7

—

(3021901) Oxygen saturation in Capillary blood

799

2067

2.89

150.68

3.4

2.6

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2915

12769

1.76

150.66

2.3

g/l

0.2

33.64

2672

11922

(3028626) Oxygen [Partial pressure] in Capillary blood

998

2915

2.56

149.51

5.1

3.8

kpa

8.2

8.5

5.80

944

2718

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

5724

29985

1.52

142.80

1.8

1.7

pmol/l

32278106.9

32073117.1

0.01

4610

24379

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

638

1504

3.16

140.88

1.7

1.5

—

(3012516) Albumin [Mass/volume] in Urine

7818

43773

1.45

138.94

3.5

3.2

mg/l

529.2

382.1

1.70

5161

26918

(40760892) CBC W Ordered Manual Differential panel - Blood

5388

28002

1.52

138.89

5.4

4.5

—

(40761535) Cells panel - Urine sediment

2587

11211

1.77

137.94

4.2

3.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

8154

46156

1.44

135.89

4.3

3.9

mg/mmol

15.1

6.5

28.84

5243

28562

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

407

720

4.18

135.64

1.4

1.2

u/l

11.6

15.7

1.84

365

690

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

759

2026

2.79

135.14

1.7

—

(3022313) Gas panel - Capillary blood

1604

5999

2.02

134.11

5.5

3.7

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

912

2699

2.53

132.84

1.5

1.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1079

3467

2.33

131.62

1.3

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2593

11391

1.74

131.51

5.5

3.4

mmol/l

1.2

25.14

2285

9781

(3023183) Ammonium ion [Moles/volume] in Plasma

874

2560

2.55

129.99

2.9

2.7

umol/l

34.2

34.8

0.30

758

2155

(3028026) IgM [Mass/volume] in Serum or Plasma

1829

7261

1.91

128.69

2.0

1.9

g/l

1.2

1.3

1.09

1668

6550

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

8923

51733

1.41

127.96

5.0

3.7

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

19667

130904

1.51

127.10

6.9

5.8

mmol/mol

40.6

39.9

19.75

17969

119551

(40758558) Short blood count panel - Blood

6326

34482

1.46

126.89

7.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

670

1733

2.88

126.25

1.5

1.3

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

19853

132483

1.51

125.62

4.8

4.0

mmol/l

1.3

22.43

18018

119030

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

741

2037

2.71

124.81

1.5

1.4

—

(3005719) IgG [Mass/volume] in Serum or Plasma

2221

9464

1.79

124.69

3.0

2.8

g/l

10.8

10.5

1.91

2036

8631

(3009508) Creatinine [Moles/volume] in Urine

7961

45640

1.41

119.51

3.4

3.2

mmol/l

6.9

7.8

66.03

6560

38021

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1187

4164

2.14

117.14

1.7

1.6

titre

183.2

257.9

0.74

196

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

599

1533

2.90

114.98

1.5

1.3

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

3153

15077

1.61

114.73

3.0

2.9

umol/l

10.4

9.3

1.49

2741

13159

(3022493) Free Hemoglobin [Mass/volume] in Plasma

286

436

4.84

113.81

8.0

1.2

mg/l

733.3

1985.3

0.55

228

292

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1372

5176

1.99

111.44

2.3

g/l

7.2

7.4

2.23

992

3807

(3037756) Immunofixation for Serum or Plasma

861

2694

2.38

111.22

1.5

1.7

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1370

5172

1.99

111.05

2.3

—

(3051593) INR in Capillary blood by Coagulation assay

282

434

4.79

111.03

13.8

3.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1634

6555

1.88

110.81

3.4

3.3

pmol/l

4.3

4.5

14.95

1460

5785

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1366

5158

1.99

110.65

2.3

g/l

3.8

0.68

960

3626

(3037522) Nuclear Ab [Titer] in Serum

3351

16392

1.57

110.42

1.4

1.3

titre

598.9

536.6

0.95

796

3421

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1294

4817

2.02

109.02

2.3

g/l

10.3

0.07

1066

3975

(40761536) Microorganisms panel - Urine sediment

2450

11213

1.66

105.53

4.9

3.8

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

804

2500

2.40

105.24

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

804

2500

2.40

105.24

1.4

1.3

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

21870

150321

1.62

104.64

29.5

14.7

umol/l

89.5

76.9

235.70

21864

150264

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

513

1278

2.97

103.20

1.7

1.6

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1378

5354

1.93

102.66

6.0

3.8

mmol/l

25.0

24.7

2.55

1275

4944

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

9348

56076

1.35

101.44

2.5

2.2

nmol/l

78.9

78.7

0.28

8217

49512

(3035880) pH of Pleural fluid

291

497

4.32

101.37

1.4

1.2

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2424

11176

1.65

101.24

2.2

2.4

nmol/l

381.4

372.2

0.99

2216

10274

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1271

4857

1.96

99.29

2.3

g/l

3.2

3.0

8.19

976

3710

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

591

1627

2.69

99.18

1.5

1.4

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

4812

25990

1.44

96.85

3.0

3.2

mmol/l

2.5

0.49

4163

22779

(3011397) Hemoglobin [Presence] in Urine by Test strip

5767

32177

1.41

96.79

4.5

3.5

—

(3004451) EKG impression Narrative

265

436

4.48

96.60

1.3

1.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

4560

24419

1.45

95.96

3.1

2.7

e6/l

1.2

1.1

0.70

2752

13887

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

20275

137630

1.45

95.46

5.5

4.6

mmol/l

6.1

6.0

14.48

18219

124010

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

20416

138802

1.46

94.94

5.4

4.5

mmol/l

4.3

4.7

307.65

18782

126639

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

20260

137552

1.45

94.76

5.4

4.4

mmol/l

1.4

1.5

75.81

18530

124685

(3019150) Specific gravity of Urine by Refractometry

5319

29379

1.41

94.16

5.3

4.0

kg/l

1.0

1.23

798

4623

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

388

862

3.32

94.10

1.7

1.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

976

3458

2.11

93.59

4.9

4.4

mg/l

1.9

1.4

33.45

885

3175

(3006184) Hemoglobin [Mass/volume] in Capillary blood

841

2808

2.23

93.47

2.7

2.0

g/l

124.2

131.7

11.78

631

1998

(44806118)

483

1232

2.90

93.25

1.6

—

(44790048)

483

1232

2.90

93.25

1.6

—

(44790049)

483

1232

2.90

93.25

1.6

—

(44790047)

483

1232

2.90

93.25

1.6

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1161

4407

1.97

92.33

2.5

g/l

0.9

1.0

0.52

985

3738

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1263

4944

1.91

91.81

1.9

1.8

u/l

38.6

39.9

1.21

1064

4412

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1324

5280

1.88

90.97

2.0

1.8

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

352

753

3.45

90.42

1.6

1.4

u/l

14.4

11.8

7.20

337

725

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

21782

150399

1.55

89.40

14.1

10.1

u/l

25.8

26.4

3.05

20945

144001

(3042631) Mycobacterium sp identified in Specimen

602

1764

2.53

89.28

2.4

2.7

—

(3011648) Oxygen content in Venous blood

363

808

3.32

87.79

3.1

3.4

10.7

10.8

0.20

363

808

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

761

2503

2.26

87.60

7.0

5.4

iu/ml

589.1

1291.7

0.54

151

374

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1227

4847

1.89

86.69

1.8

1.7

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

968

3521

2.05

86.54

1.8

1.5

g/l

1.1

1.2

8.62

908

3328

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1025

3816

2.00

85.99

2.4

2.3

g/l

0.0

0.35

923

3487

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

20737

141968

1.45

85.77

6.1

5.0

mmol/l

2.4

2.8

307.65

19036

128887

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

968

3539

2.04

85.35

2.4

2.3

g/l

0.0

0.12

868

3223

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

629

1924

2.42

85.24

1.5

1.4

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

939

3405

2.06

84.62

1.8

1.5

g/l

0.2

3.99

880

3200

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

952

3488

2.03

83.43

2.4

g/l

0.0

0.00

866

3210

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1061

4044

1.96

83.26

2.3

2.2

g/l

36.7

38.4

15.59

910

3411

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

722

2388

2.25

82.00

1.3

1.2

titre

71.4

166.1

1.13

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

838

2958

2.11

81.03

2.0

1.9

mg/l

12.5

10.9

2.49

767

2743

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

292

595

3.62

80.57

2.2

2.7

90.0

98.7

3.65

284

563

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

609

1903

2.37

78.77

3.3

3.0

u/ml

2371.3

6215.4

0.41

135

(3017143) Hepatitis C virus Ab [Presence] in Serum

2507

12353

1.54

77.95

1.8

1.5

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

207

333

4.57

77.57

1.6

1.3

65.8

58.7

1.72

165

288

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

923

3438

2.00

77.24

1.6

1.5

iu/ml

18.8

13.5

0.53

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

17.96

76.53

10.8

11.2

—

(3003694) ABO and Rh group [Type] in Blood

6334

37034

1.34

75.69

1.4

1.3

—

(40768797) Stomach Pathology biopsy report

3560

18936

1.44

75.56

1.3

1.2

—

(3026250) Tacrolimus [Mass/volume] in Blood

247

479

3.79

73.08

40.5

33.7

ug/l

7.3

7.2

0.52

230

434

(21494755) Public health laboratory ask at order entry panel

723

10295

0.50

72.97

1.3

1.4

—

(3017181) Myelocytes/100 leukocytes in Blood

2354

11628

1.53

72.03

4.4

4.0

1.0

0.9

0.13

790

3244

(21494890) Protein electrophoresis panel - 24 hour Urine

453

1294

2.59

70.75

1.9

2.2

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

13413

87303

1.27

68.27

3.6

3.0

u/l

61.7

50.4

27.73

12279

80220

(3021440) Promyelocytes/100 leukocytes in Blood

2237

11057

1.53

68.05

4.4

4.1

0.1

0.11

744

3000

(3000093) Morphology [Interpretation] in Blood Narrative

428

1213

2.61

67.91

1.2

1.1

—

(3002179) Metamyelocytes/100 leukocytes in Blood

2144

10543

1.53

66.72

4.3

3.9

0.6

0.7

0.02

599

2340

(3042733) HLA Ab [Presence] in Serum

191

330

4.25

65.74

5.2

4.6

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

588

1963

2.22

65.29

1.2

1.4

u/l

41.2

34.1

0.69

521

1668

(3000494) Fungus identified in Specimen by Culture

3053

16201

1.43

64.74

1.6

1.4

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

19480

133388

1.33

64.43

22.7

11.9

ml/min/173m2

72.8

79.7

307.65

17017

107936

(3025159) Blasts/100 leukocytes in Blood

2107

10411

1.52

64.00

4.4

4.1

0.2

0.3

0.14

651

2539

(3007164) IgA [Mass/volume] in Serum or Plasma

4231

23815

1.36

63.12

1.6

1.5

g/l

2.7

2.5

4.75

2649

13515

(3001893) Eosinophils/100 leukocytes in Pleural fluid

172

284

4.45

62.58

1.6

1.3

1.7

3.0

1.65

141

250

(3023383) Lactate [Moles/volume] in Pleural fluid

170

280

4.46

62.04

1.5

1.3

mmol/l

2.8

4.4

5.36

155

263

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

4048

22721

1.36

61.27

3.4

2.9

e6/l

2.3

2.4

0.06

2256

12288

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2695

14115

1.44

61.09

1.8

1.5

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

658

2386

2.04

59.20

1.8

1.4

—

(3052851) Hemolysis interference index of Serum or Plasma

937

3830

1.82

59.18

4.4

3.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

606

2140

2.10

58.48

1.8

1.4

u/ml

127.1

108.9

1.27

164

459

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

9067

57007

1.26

58.10

5.0

5.1

ug/l

2.8

3.5

3.29

7911

51321

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

654

2383

2.03

58.07

1.8

1.4

u/ml

14.6

19.4

0.63

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

17.39

56.63

1.2

1.1

ug/l

102.1

123.2

0.20

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1563

7417

1.58

56.62

2.6

2.4

—

(4010399)

1994

10004

1.50

56.00

1.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

289

737

2.89

55.95

1.6

1.4

—

(3002385) Erythrocyte distribution width [Ratio]

16962

114714

1.26

55.84

29.7

15.6

14.1

13.6

225.62

16648

111958

(3042111) Morphology [Interpretation] in Bone marrow Narrative

616

2228

2.05

55.81

1.5

1.6

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

382

1131

2.49

55.53

3.4

2.6

—

(3003181) Sodium [Moles/volume] in Urine

636

2332

2.02

55.52

1.4

mmol/l

61.1

65.3

1.77

519

1859

(3011335) Digoxin [Mass/volume] in Serum or Plasma

+∞

55.19

2.6

0.0

—

(3014891) Appearance of Pleural fluid

7.18

55.16

1.7

1.6

—

(3025941) Bacteria identified in Stool by Culture

1427

6677

1.60

54.82

1.4

1.2

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

226

505

3.29

54.49

1.2

1.1

iu/ml

4.7

3.1

1.25

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

140

223

4.61

53.20

1.6

1.3

21.1

22.4

0.19

117

196

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

260

643

2.97

53.13

1.6

1.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

5919

35669

1.28

52.75

4.3

3.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

260

646

2.96

52.71

1.6

1.5

—

(3034770) Mitochondria Ab [Titer] in Serum

813

3296

1.83

52.70

1.2

titre

870.6

957.7

0.15

101

(3007461) Platelets [#/volume] in Blood

22220

156305

1.44

52.36

36.7

18.7

e9/l

230.8

249.9

307.65

21751

150971

(46235355) HIV 1 and 2 tests - Meaningful Use set

3008

16474

1.38

52.25

1.9

1.7

—

(3020876) Protein [Mass/time] in 24 hour Urine

358

1059

2.49

52.17

2.1

2.0

g/24h

1.0

0.8

0.09

(3037121) Protein [Mass/volume] in Urine

1068

4708

1.69

51.84

3.1

3.4

g/l

0.3

1.25

505

2069

(3035941) MCH [Entitic mass]

22220

156378

1.43

51.25

36.6

18.6

30.4

0.89

21927

153474

(3010813) Leukocytes [#/volume] in Blood

22224

156431

1.43

50.95

36.7

18.7

e9/l

7.0

6.7

33.05

21683

150502

(3024731) MCV [Entitic volume]

22220

156401

1.43

50.90

36.6

18.6

91.7

91.1

60.35

21926

153483

(3026361) Erythrocytes [#/volume] in Blood

22221

156412

1.43

50.86

36.7

18.7

e12/l

4.3

4.5

307.65

21682

150448

(3000963) Hemoglobin [Mass/volume] in Blood

22223

156446

1.43

50.60

37.0

18.8

g/l

129.5

136.4

307.65

21935

153523

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

864

3621

1.77

50.18

2.0

1.7

—

(3007566) Smooth muscle Ab [Titer] in Serum

807

3323

1.80

49.72

1.2

titre

131.2

134.5

0.03

281

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1046

4657

1.67

48.89

1.2

u/ml

2.1

0.7

1.64

102

422

(3000919) Neutrophils/100 leukocytes in Pleural fluid

146

260

4.12

48.50

1.5

1.3

20.9

24.6

0.68

129

239

(3010375) cycloSPORINE [Mass/volume] in Blood

217

509

3.13

48.49

28.2

ug/l

108.2

118.6

1.45

168

447

(3019225) pH of Specimen

2686

14607

1.39

48.43

5.4

3.9

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

4616

27231

1.29

47.83

1.3

u/ml

2.2

1.9

0.58

1208

6837

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

160

309

3.80

47.77

1.6

2.4

208.8

163.5

4.19

155

295

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

873

10461

0.60

47.52

1.9

1.8

—

(3023419) Bacteria identified in Sputum by Culture

455

1562

2.15

47.24

2.3

2.6

—

(3040151) Glucose [Moles/volume] in Capillary blood

418

1407

2.19

45.58

6.2

6.4

mmol/l

7.1

7.5

1.76

361

1163

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

133

5.46

45.31

1.6

1.3

9.8

11.7

0.30

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

598

2305

1.92

45.30

1.4

1.3

—

(3009542) Hematocrit [Volume Fraction] of Blood

18239

125409

1.25

44.87

26.5

13.9

37.9

39.7

88.89

10884

86969

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

528

1956

1.99

44.84

1.3

1.2

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

189

428

3.24

44.72

1.6

2.3

172.9

147.5

2.85

179

404

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

566

2154

1.94

44.52

1.5

1.3

u/ml

287.8

270.6

0.68

385

1308

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

237

616

2.83

44.45

1.5

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

237

616

2.83

44.45

1.5

1.6

—

(40757494) Bilirubin.total [Moles/volume] in Blood

239

625

2.81

44.33

2.2

umol/l

15.5

46.3

1.72

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

838

3611

1.72

44.16

1.5

1.4

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

585

2278

1.90

42.99

5.8

2.6

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

476

1726

2.03

42.89

1.3

1.2

u/ml

5.5

3.9

0.64

199

597

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

334

1053

2.34

42.49

1.5

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

334

1053

2.34

42.49

1.5

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

334

1053

2.34

42.49

1.5

1.7

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

6.37

42.47

1.3

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

134

5.25

42.27

1.4

1.2

mmol/l

0.5

1.9

2.01

(3024891) Influenza virus A+B Ag [Presence] in Specimen

690

2858

1.79

41.69

1.2

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

147

296

3.64

41.48

1.4

1.2

ug/l

229.9

479.6

0.61

177

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

458

1665

2.03

41.00

1.3

1.2

u/ml

4.9

3.7

1.19

223

733

(4094501)

818

3577

1.69

40.86

1.1

—

(3044927) Protein electrophoresis panel - Urine

383

1308

2.16

40.35

1.2

—

(44786800) Granulocytes/100 leukocytes in Body fluid

119

5.42

40.05

1.5

1.3

19.0

28.5

1.54

101

(3016750) Collection duration of Urine

271

800

2.49

39.78

2.4

2.1

min

501.5

498.0

0.21

206

599

(3041918) Cholesterol [Moles/volume] in Pleural fluid

108

178

4.45

39.54

1.3

1.1

mmol/l

1.2

2.1

9.90

110

(3000012) Reticulocyte production index

257

745

2.54

39.17

1.5

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

140

285

3.60

38.93

1.3

1.1

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2283

12547

1.36

38.03

2.6

2.5

u/l

43.9

51.8

0.43

1960

10721

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

262

780

2.47

37.81

1.4

—

(3051651) Icteric interference index of Serum or Plasma

247

717

2.53

37.56

5.7

3.9

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

265

796

2.45

37.53

1.4

—

(3019977) pH of Arterial blood

220

604

2.68

37.35

2.8

2.3

7.4

1.14

227

(3019768) Coxiella burnetii Ab [Presence] in Serum

8.18

37.14

1.3

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

258

770

2.46

37.05

2.1

1.7

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

102

5.60

36.74

1.5

1.2

u/l

47.8

385.2

0.70

(3049717) Cytology report of Urine Cyto stain

1156

5643

1.52

36.60

2.7

2.8

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

360

1249

2.12

36.49

1.6

1.7

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

6.78

35.39

1.3

1.1

mg/l

6.4

9.3

1.14

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

248

744

2.45

35.25

1.2

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

786

3538

1.64

35.18

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

379

1362

2.05

35.06

1.6

1.7

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

534

6715

0.57

34.79

1.5

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

790

3572

1.64

34.74

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

791

3583

1.63

34.53

1.2

—

(3008037) Lactate [Moles/volume] in Venous blood

684

2989

1.69

34.27

4.3

2.6

mmol/l

1.6

0.38

671

2932

(3033705) Calcium.ionized [Moles/volume] in Venous blood

420

1581

1.96

34.18

3.1

1.9

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

135

297

3.33

33.54

1.4

g/l

15.5

11.3

5.54

109

219

(40762365) Oxygen content in Arterial blood by calculation

104

191

3.99

33.35

2.5

3.5

ml/dl

15.3

14.8

0.93

183

(3012565) Volume of 24 hour Urine

217

628

2.54

33.27

2.4

2.1

1682.0

2029.2

5.58

187

557

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

370

1349

2.02

32.95

1.2

u/l

80.1

69.6

0.29

266

875

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

324

1130

2.11

32.46

2.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

316

1094

2.12

32.27

1.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

3629

21732

1.26

31.70

1.3

iu/ml

35.6

40.5

0.88

1090

6817

(3017704) Immunofixation for Urine

225

682

2.42

31.35

1.4

1.7

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

7104

45649

1.19

30.84

4.5

4.3

22.5

21.7

3.96

3572

23050

(3000492) Spirometry study

2114

11840

1.33

30.79

1.6

1.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

11264

75252

1.17

30.78

2.6

2.5

—

(3051611) Lipemic interference index of Serum or Plasma

370

1387

1.96

30.53

5.1

3.3

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

750

3458

1.60

30.50

2.7

2.4

ug/min

134.4

95.4

1.40

453

2018

(3038515) Glucose [Moles/volume] in Venous blood

645

2870

1.66

30.22

4.5

2.6

mmol/l

7.4

7.6

0.89

635

2823

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

275

933

2.17

29.59

1.8

1.6

—

(4268621)

313

1120

2.05

29.38

2.4

2.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

534

2275

1.73

29.37

3.6

3.4

1.4

1.5

0.25

440

1733

(3004775) Volume in Urine collected for unspecified duration

319

1151

2.04

29.28

2.6

2.2

681.1

676.3

0.07

235

773

(3000475) Leukocytes [#/volume] in Synovial fluid

721

3328

1.60

29.19

1.8

1.6

e6/l

17778.8

12411.7

1.58

542

2390

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1506

8065

1.39

29.17

1.4

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

151

391

2.83

28.71

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

794

3767

1.56

28.59

1.7

1.6

iu/ml

28.2

7.4

0.57

172

827

(3024471) HLA-A [Type]

150

388

2.84

28.57

1.0

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

189

552

2.51

28.52

2.5

2.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

705

3261

1.60

28.30

1.4

1.3

—

(3024932) HLA-DR beta [Type]

147

379

2.84

28.17

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

432

1757

1.81

27.84

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

145

376

2.83

27.52

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

225

726

2.28

27.34

1.4

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

196

597

2.41

27.10

1.3

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

196

597

2.41

27.10

1.3

1.5

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

147

393

2.74

26.41

2.3

1.8

e6/l

26895.0

6824.4

0.99

209

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

5.04

26.32

1.2

1.1

u/l

15.4

25.6

3.24

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

424

1746

1.79

26.26

1.4

1.3

nmol/l

5.1

1.5

0.58

409

1686

(3047189) Immunofixation for 24 hour Urine

192

588

2.40

26.26

1.6

1.8

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

3372

20434

1.24

26.01

1.2

u/ml

13.0

14.2

0.27

1185

7490

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

424

1752

1.78

25.96

1.4

1.3

nmol/l

0.2

0.3

0.36

134

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

654

3039

1.59

25.78

1.3

u/ml

3.5

0.00

310

(3011985) Renin [Units/volume] in Plasma

410

1685

1.79

25.57

1.3

1.4

mu/l

78.8

66.1

0.40

360

1500

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

659

3075

1.58

25.53

1.3

u/ml

10.9

5.8

1.15

131

497

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

485

2097

1.70

25.36

1.2

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

4.73

25.35

1.7

1.3

78.7

71.0

1.03

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

620

2857

1.60

25.32

1.3

1.4

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

6.60

25.31

1.3

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

464

1997

1.71

24.68

1.5

1.6

g/l

0.8

0.31

324

1500

(3027135) IgG subclass 1 [Mass/volume] in Serum

321

1235

1.91

24.65

1.4

g/l

7.5

6.7

2.25

220

856

(3024139) IgG subclass 3 [Mass/volume] in Serum

320

1235

1.90

24.36

1.4

g/l

0.5

0.4

1.84

218

852

(3028192) IgG subclass 2 [Mass/volume] in Serum

320

1236

1.90

24.30

1.4

g/l

2.8

2.9

0.21

217

857

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

561

2560

1.61

23.87

1.3

1.2

u/ml

3.2

4.8

0.46

189

(3023487) Leukocytes [#/volume] in Peritoneal fluid

158

463

2.50

23.77

2.5

2.0

e6/l

5639.9

4641.0

0.08

119

312

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

171

3.60

23.55

1.3

1.6

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

121

310

2.86

23.54

1.2

93.3

106.3

2.27

110

284

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

119

304

2.87

23.28

1.1

74.6

88.9

4.18

137

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1367

7471

1.36

23.27

3.3

2.6

e6/l

0.3

0.23

1332

7310

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

233

816

2.10

23.26

1.6

1.5

u/l

9.0

5.8

0.96

127

373

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

691

3331

1.53

23.22

1.3

1.2

u/ml

32.3

42.1

0.50

197

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

129

4.03

23.21

1.1

1.3

nmol/l

6.4

347715.2

1.08

109

(3017569) Oxygen content in Arterial blood

173

536

2.37

23.13

2.3

2.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

371

1528

1.79

23.03

1.4

1.3

nmol/l

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

323

1277

1.86

22.88

1.5

1.3

e6/l

176251.1

89407.1

1.12

232

865

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

404

1710

1.74

22.84

1.6

1.5

64.9

56.1

4.44

273

1051

(3033799) Differential panel - Peritoneal fluid

140

395

2.60

22.76

2.4

1.8

—

(4062490)

313

1229

1.87

22.65

1.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

384

1609

1.76

22.50

1.4

1.3

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

215

742

2.13

22.31

1.3

1.2

u/l

116.4

83.5

2.70

193

637

(3016038) Potassium [Moles/volume] in Urine

243

880

2.03

22.22

1.2

mmol/l

35.0

34.4

0.14

210

746

(3005322) IgE [Units/volume] in Serum or Plasma

1330

7292

1.35

22.17

1.3

u/ml

232.7

275.1

0.85

1212

6718

(3021788) Differential panel - Synovial fluid

539

2483

1.60

22.09

1.6

1.5

—

(21494434) Karyotype in Bone marrow

311

1229

1.86

22.08

1.1

1.2

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

555

2583

1.58

21.80

1.3

1.2

u/ml

9.7

15.2

0.28

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

316

1261

1.84

21.76

1.6

1.5

24.2

32.3

4.02

204

746

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

379

1598

1.74

21.75

1.2

1.3

pmol/l

274.0

289.7

0.26

296

1207

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

209

721

2.13

21.72

1.3

1.2

u/l

28.8

22.3

1.05

184

599

(40768446) Kidney Pathology biopsy report

160

493

2.38

21.69

1.8

1.7

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

400

1718

1.71

21.50

1.1

g/l

1.6

1.5

3.39

362

1547

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

114

299

2.79

21.31

1.2

1.1

72.0

91.2

4.81

137

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

188

628

2.20

21.18

1.2

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

192

3.28

21.07

1.2

1.1

77.3

82.1

0.42

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

4.50

21.03

2.4

1.8

63.6

54.1

0.87

(3014271) Vancomycin [Susceptibility]

198

679

2.14

20.91

3.2

2.8

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

161

3.50

20.82

5.0

5.9

ug/min

59.0

43.7

0.97

125

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2662

16081

1.23

20.81

3.5

4.4

ug/l

27.4

27.1

0.01

2175

13275

(3044416) Complement C4 [Mass/volume] in Pleural fluid

6.93

20.67

1.1

1.2

g/l

0.1

0.97

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

177

584

2.22

20.55

3.3

4.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

190

3.24

20.19

1.2

1.1

74.4

71.5

0.21

(3011412) CD3 cells [#/volume] in Blood

307

1248

1.81

19.97

2.4

2.6

e9/l

1.0

1.2

1.21

190

748

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

172

568

2.22

19.95

2.3

1.8

u/ml

1398.0

1425.9

0.03

167

560

(4034850)

844

4372

1.42

19.79

16.6

8.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

387

1686

1.69

19.79

1.2

1.1

106.3

119.6

10.97

356

1510

(3001019) Free T4 and TSH panel - Serum or Plasma

422

4889

0.62

19.74

1.6

—

(3034426) Prothrombin time (PT)

125

360

2.54

19.58

1.3

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

306

1257

1.79

19.25

3.6

3.8

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

799

4121

1.43

19.20

1.4

ug/g

253.8

268.1

1.22

486

2411

(3008757) Leukocyte morphology finding [Identifier] in Blood

365

1584

1.69

18.96

4.0

3.9

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

345

1481

1.71

18.65

1.2

u/ml

64.3

59.7

0.13

(3037692) Legionella sp identified in Specimen by Organism specific culture

144

455

2.32

18.54

1.4

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

+∞

18.39

1.9

0.0

umol/l

0.6

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

643

3210

1.48

18.34

1.4

1.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

162

542

2.19

18.26

2.2

1.7

—

(3022145) Colonoscopy Study observation

2622

16031

1.22

18.11

1.3

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

200

3.04

18.06

4.9

6.3

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

142

452

2.30

18.00

2.2

1.8

u/ml

43035.0

28484.1

0.13

(3002256) Pathology report gross observation

3034

18828

1.20

17.95

1.4

1.3

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

249

982

1.86

17.89

1.2

titre

146.7

172.8

0.27

181

(4306422)

386

1728

1.64

17.85

1.2

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

101

274

2.70

17.82

1.6

1.4

g/l

28.1

28.7

0.04

208

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

248

981

1.86

17.66

1.2

titre

213.6

103.6

0.44

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

9.14

17.64

7.8

7.9

43.9

54.0

0.79

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

114

334

2.50

17.31

3.0

2.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

114

334

2.50

17.31

3.0

2.1

—

(3010503) CD19 cells [#/volume] in Blood

208

782

1.95

17.26

2.3

2.7

e9/l

0.6

0.4

0.19

200

761

(3025315) Body weight

4.43

17.00

6.3

3.8

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

4.43

17.00

2.2

1.8

8.9

29.9

2.75

(1175426) CD3 cells/100 lymphocytes in Blood

245

982

1.83

16.77

2.2

2.3

71.1

71.3

0.07

231

941

(3018738) Hemoglobin F/Hemoglobin.total in Blood

4.73

16.73

6.1

2.9

9.6

12.1

0.25

(3044007) Cell count panel - Peritoneal fluid

121

372

2.38

16.61

2.7

1.8

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

385

1755

1.61

16.60

1.4

—

(3008295) Osmolality of Serum or Plasma

313

1353

1.70

16.56

1.3

1.4

mosm/kgh2o

276.1

280.0

1.80

253

1046

(3024522) Salmonella sp identified in Specimen by Organism specific culture

377

1713

1.62

16.48

1.4

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

229

905

1.86

16.40

2.3

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

240

964

1.83

16.33

2.2

14.0

14.2

0.06

447

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

384

1762

1.60

16.13

1.2

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

124

391

2.32

16.11

1.3

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

371

1689

1.61

16.10

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

375

1714

1.61

16.01

1.4

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

6.82

15.90

1.3

1.0

ng/l

3203.7

1244.7

1.14

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

5.33

15.86

1.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

370

1694

1.60

15.70

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

370

1697

1.60

15.59

1.4

—

(3020961) Endomysium IgA Ab [Titer] in Serum

1004

5566

1.33

15.56

1.1

titre

133.5

215.9

1.09

152

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

254

1055

1.77

15.51

1.7

2.0

mg/l

4.4

3.6

1.80

244

1003

(3044941) Cell count panel - Synovial fluid

440

2112

1.53

15.23

1.5

1.4

—

(40768443) Skin Pathology biopsy report

1126

6374

1.30

15.05

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

177

661

1.96

15.05

1.2

1.1

ratio

1.1

0.43

236

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

116

368

2.31

14.91

1.3

1.4

pmol/l

15.4

14.8

0.62

309

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

113

355

2.33

14.85

1.1

—

(3017732) Neutrophils [#/volume] in Blood

1585

9377

1.25

14.84

3.0

2.9

e9/l

4.4

4.0

3.25

1105

7004

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

193

2.84

14.66

2.6

3.0

mg/l

50.9

51.4

—

(3045142) Bone marrow Pathology biopsy report

351

1616

1.60

14.60

1.2

1.4

—

(3016228) CD19 cells/100 cells in Blood

145

512

2.08

14.38

2.2

2.0

9.7

8.5

0.39

139

498

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

139

485

2.10

14.23

2.5

2.9

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

303

1356

1.64

14.15

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

4.88

14.05

3.6

2.6

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

139

489

2.08

13.94

1.2

1.1

u/ml

28.2

5.2

0.61

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

479

2386

1.48

13.93

1.2

u/ml

46.1

43.3

0.16

222

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

120

401

2.19

13.70

2.3

2.0

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

971

5458

1.31

13.69

1.3

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

316

1442

1.61

13.67

3.7

3.5

62.4

57.6

3.00

231

901

(21494814) CD8 cells/100 lymphocytes in Specimen

140

498

2.06

13.65

2.2

2.0

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

5774

38351

1.13

13.57

1.7

1.6

mmol/l

1.3

1.4

2.74

4635

31897

(3014148) Varicella zoster virus Ab [Titer] in Serum

291

1305

1.64

13.50

1.2

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

163

617

1.94

13.39

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

381

1832

1.53

13.16

2.5

1.9

mg/l

22.5

28.7

1.38

482

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

3.58

13.00

1.1

iu/ml

9.8

24.3

0.79

(3004616) Nuclear Ab [Presence] in Serum

330

1544

1.57

12.88

1.4

1.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

445

2223

1.47

12.80

1.2

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

118

404

2.14

12.73

1.5

1.3

60.9

52.2

1.57

347

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

7.31

12.61

8.9

7.4

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

130

3.10

12.49

1.3

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

396

1945

1.50

12.40

1.7

2.0

ug/l

23.2

24.8

0.19

380

1913

(40757373) Influenza virus identified in Isolate

225

2.54

12.36

1.4

1.7

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

395

1942

1.49

12.32

1.1

—

(3012898) Urea [Moles/volume] in Urine

106

3.31

12.13

1.2

1.6

mmol/l

157.8

186.8

0.70

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

231

1006

1.68

12.05

1.6

u/ml

26.0

23.8

0.26

216

(3050794) Legionella sp Ab [Presence] in Serum

103

3.34

12.02

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

278

1272

1.60

11.96

1.2

1.1

89.0

97.6

5.67

263

1182

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

528

2760

1.41

11.93

1.8

iu/l

22.3

11.2

0.26

169

958

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

5.85

11.93

6.4

6.0

umol/l

396.8

468.1

0.70

(1761482) Bacteria [#/volume] in Urine by Culture

725

3996

1.34

11.78

4.4

3.9

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

170

683

1.82

11.72

1.2

1.1

u/l

40.6

23.7

1.18

132

503

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

170

684

1.82

11.67

1.2

1.1

u/l

110.1

81.6

2.07

138

527

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

306

1441

1.56

11.67

1.2

1.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

170

685

1.82

11.62

1.5

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

170

685

1.82

11.62

1.5

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

170

685

1.82

11.62

1.5

1.9

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

3.53

11.39

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1000

9142

0.79

11.32

1.3

1.4

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

169

686

1.81

11.29

1.5

1.9

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

162

650

1.83

11.24

1.6

1.5

2.5

4.3

1.07

125

(3032743) Legionella sp IgG Ab [Presence] in Serum

3.52

11.11

1.1

—

(3045716) Anion gap in Serum or Plasma

142

550

1.89

11.00

3.1

2.3

mmol/l

8.9

9.4

0.71

101

400

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

287

1351

1.56

10.99

1.2

1.1

iu/ml

1.8

2.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

215

947

1.66

10.81

1.2

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

334

1632

1.50

10.80

2.0

2.2

titre

3.9

7.0

—

(3052592) Norovirus Ag [Presence] in Stool

234

2.38

10.58

1.3

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

128

2.91

10.54

2.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

137

2.83

10.40

2.0

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

339

2.12

10.40

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

2913

18795

1.15

10.35

5.2

4.6

33.4

32.2

7.36

2047

11954

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

391

1995

1.44

10.18

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

300

1452

1.52

10.17

1.1

—

(40768804) Tissue Pathology biopsy report

8361

57356

1.10

10.16

2.2

2.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

164

2.63

10.14

1.0

1.1

—

(21494815) CD4 cells/100 lymphocytes in Specimen

245

1139

1.58

9.96

2.2

2.4

40.0

37.9

0.19

136

(4015189)

103

370

2.04

9.93

2.4

2.3

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

172

2.55

9.73

1.0

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

125

487

1.88

9.58

1.1

90.5

98.4

1.54

105

386

(3026389) Candida sp identified in Specimen by Organism specific culture

368

1880

1.44

9.55

1.4

1.3

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1972

16613

0.86

9.46

1.4

—

(3028433) Virus identified in Specimen by Culture

118

454

1.90

9.40

1.2

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

198

2.40

9.32

2.6

1.9

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

201

909

1.62

9.20

2.2

2.8

e6/l

410.9

581.5

2.95

163

766

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

131

2.74

9.10

1.1

—

(3000330) Specific gravity of Urine by Test strip

1211

7351

1.21

8.95

4.2

3.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

136

557

1.79

8.94

1.6

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

136

557

1.79

8.94

1.6

2.0

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

114

443

1.88

8.85

2.4

1.4

ug/l

23.0

548.8

1.42

107

416

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

116

455

1.87

8.76

2.8

2.1

—

(3048879) Bone marrow aspiration report

107

409

1.91

8.73

1.4

1.8

—

(3006270) Folate [Moles/volume] in Blood

235

1119

1.54

8.67

1.2

1.1

nmol/l

315.2

349.5

1.87

199

917

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

136

563

1.77

8.64

1.6

2.0

—

(3036670) Protein [Mass/volume] in Synovial fluid

109

421

1.90

8.63

1.2

g/l

39.7

39.5

0.04

221

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

184

828

1.63

8.62

1.3

titre

121.9

60.8

0.35

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

174

2.44

8.62

1.7

2.0

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

366

1.96

8.56

2.2

2.0

u/l

43.2

35.8

0.14

332

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

188

855

1.61

8.45

1.4

1.3

titre

227.3

445.5

0.67

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

156

676

1.69

8.45

3.5

3.3

—

(3003338) MCHC [Mass/volume]

16452

116789

1.09

8.35

33.0

16.5

g/l

330.8

332.9

150.43

16302

115891

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

184

836

1.61

8.31

1.4

umol/l

14.9

12.4

4.10

179

790

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

147

630

1.71

8.30

1.2

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

366

1.94

8.24

1.8

1.6

ug/l

10.2

9.2

1.25

366

(3039443) Prostate specific Ag panel - Serum or Plasma

310

3189

0.71

8.20

1.5

1.6

—

(21491868) Cryoglobulin [Mass/volume] in Serum

105

408

1.88

8.19

1.2

g/l

0.6

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

189

869

1.59

8.14

2.4

2.9

e9/l

0.2

3.15

164

761

(3028300) Cannabinoids [Presence] in Urine

302

3110

0.71

8.05

2.7

2.1

—

(3005570) Glucose [Moles/volume] in Urine

274

1370

1.47

8.04

2.1

1.8

—

6.8

—

(3000764) Benzodiazepines [Presence] in Urine

299

3083

0.70

8.03

2.6

2.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

241

2.16

8.01

1.2

1.1

—

(3036603) Volume of Urine

189

874

1.58

7.96

1.7

1.6

1781.2

2054.6

1.58

205

(3027008) Opiates [Presence] in Urine

302

3104

0.71

7.96

2.5

2.0

—

(3027944) Amphetamines [Presence] in Urine

295

3038

0.71

7.87

2.3

2.0

—

(3035637) Corticotropin [Mass/volume] in Plasma

326

1692

1.41

7.85

1.4

1.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

446

4301

0.75

7.79

2.0

1.4

mg/l

4.2

3.5

0.55

311

2986

(3048689) Calprotectin [Mass/mass] in Stool

2327

15091

1.14

7.62

2.1

2.3

ug/g

154.9

140.5

1.02

1821

11723

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

122

510

1.75

7.56

1.5

1.7

nmol/l

5.2

9.8

0.42

105

421

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

212

1020

1.52

7.53

1.3

1.2

u/ml

15.4

40.5

2.88

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

172

2.34

7.53

1.2

1.3

ng/l

100.6

149.9

0.46

118

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

211

1017

1.52

7.44

1.3

1.2

u/ml

45.9

84.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

917

5536

1.22

7.23

2.9

3.6

u/ml

557.4

1354.3

1.73

759

4790

(3038026) Centromere Ab [Units/volume] in Serum

215

1048

1.50

7.21

1.3

1.2

u/ml

35.4

53.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

955

8359

0.83

7.21

1.8

1.9

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

202

972

1.52

7.20

1.3

1.2

u/ml

13.5

5.5

0.39

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

257

1302

1.45

7.11

1.3

1.2

—

(3003129) Base excess in Capillary blood by calculation

355

1.88

7.08

2.1

1.6

mmol/l

1.8

0.3

2.62

338

(3009871) Measles virus Ab [Titer] in Serum

368

1.85

6.93

1.5

1.8

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

163

754

1.58

6.93

2.6

2.9

38.7

37.3

0.27

240

(3016879) Cocaine [Presence] in Urine

285

2885

0.72

6.92

2.6

2.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

789

4715

1.23

6.89

1.7

1.6

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

237

2.07

6.87

1.2

1.1

umol/24h

0.6

0.7

0.04

103

(3046861) Legionella sp Ag [Presence] in Urine

3.20

6.85

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

228

2.09

6.81

1.4

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

339

1.88

6.81

1.1

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

692

4090

1.24

6.70

1.6

1.7

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

206

1012

1.49

6.69

2.3

2.7

e6/l

523.6

769.7

1.23

392

(3043410) Blood group antigens tested for on Red Blood Cells

345

1.85

6.48

2.4

1.8

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

564

3271

1.27

6.46

3.0

3.5

u/ml

1665.6

791.8

0.36

513

2973

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

289

1.92

6.42

1.2

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2.99

6.37

1.0

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

255

1.98

6.33

2.4

2.5

mmol/l

7.9

7.6

0.17

151

(3013139) Helicobacter pylori Ag [Presence] in Stool

1416

9006

1.16

6.15

1.2

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

244

1.98

6.06

1.1

pmol/l

3.6

9.5

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

226

2.01

5.93

1.3

1.4

titre

147.5

154.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

231

1.99

5.93

1.6

1.5

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

154

732

1.54

5.89

1.7

1.9

u/field

1.4

2.9

2.31

105

503

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

4873

33304

1.09

5.82

3.1

3.0

ug/l

0.8

0.21

3457

22572

(3006922) Hepatitis E virus Ab [Presence] in Serum

173

847

1.50

5.78

1.1

—

(1761868) Lipid panel - Serum or Plasma

6070

46886

0.93

5.71

3.5

2.9

—

(3045414) Leukocytes [Presence] in Urine

986

6139

1.18

5.64

2.1

1.8

—

(4024509)

252

1332

1.39

5.60

1.7

1.5

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

244

1287

1.39

5.50

1.3

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

103

452

1.67

5.50

1.2

—

(4146454)

318

1751

1.33

5.46

2.9

2.7

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

219

1.97

5.41

4.5

2.9

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

363

2040

1.30

5.40

2.6

2.7

u/ml

243.4

1043.3

1.29

355

1995

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1156

0.62

5.31

1.3

1.5

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

13.15

5.22

1.0

2.0

—

(3006462) Nitrate [Presence] in Urine

140

671

1.53

5.22

4.3

3.3

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

902

0.57

5.19

1.4

1.5

—

(3032057) Clostridioides difficile [Presence] in Stool

270

1.84

5.13

1.6

1.7

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

241

2378

0.74

5.09

2.6

2.2

—

(3037556) Urate [Mass/volume] in Serum or Plasma

390

1.69

5.07

1.7

1.3

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

877

0.57

5.06

1.4

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

184

939

1.43

5.04

1.1

mg/l

304.4

282.5

3.35

166

845

(3018291) Platelet Ab [Presence] in Serum

4.87

5.02

1.1

—

(3005033) Fetal Nuchal fold Thickness US

874

0.58

5.00

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

429

3913

0.80

4.97

1.9

—

(3020618) Glucose [Moles/volume] in Synovial fluid

3.31

4.94

1.0

mmol/l

5.6

5.4

0.12

(3001964) Herpes simplex virus Ag [Presence] in Specimen

373

1.69

4.85

1.7

1.6

—

(4211845)

150

742

1.48

4.85

4.1

3.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

108

497

1.59

4.84

1.1

miu/ml

1608.7

1545.0

0.24

108

497

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

346

1.71

4.82

1.1

1.3

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

209

1101

1.39

4.81

1.9

2.0

u/field

2.1

2.4

0.28

428

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

236

2311

0.74

4.77

3.5

3.7

u/ml

38.7

44.7

0.19

223

2251

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

890

7546

0.86

4.73

1.7

1.8

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1069

0.63

4.72

1.4

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

107

2.32

4.72

1.4

ml/s/173m2

0.7

1.3

2.36

(3019174) dRVVT (LA screen)

2.46

4.72

1.1

1.2

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

121

2.24

4.72

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1068

0.63

4.71

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1068

0.63

4.71

1.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

161

814

1.45

4.67

1.3

1.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.41

4.66

3.8

3.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1064

0.63

4.64

1.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

107

1196

0.65

4.61

1.4

1.3

pmol/l

67.0

96.5

0.56

377

(3006407) Chromogranin A [Mass/volume] in Serum or Plasma

+∞

4.60

1.2

0.0

ug/l

184.4

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

154

777

1.45

4.53

1.0

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

149

747

1.46

4.53

1.4

1.3

nmol/l

1.2

0.06

118

571

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

385

3511

0.80

4.49

1.4

1.3

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

117

559

1.53

4.49

1.3

1.6

umol/l

20.0

26.4

1.63

109

533

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

154

779

1.45

4.48

1.0

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

171

886

1.41

4.38

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

170

880

1.41

4.37

1.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

3.27

4.37

2.8

3.6

—

(3023420) DNA double strand Ab [Units/volume] in Serum

230

1252

1.35

4.36

1.7

1.4

iu/ml

27.1

23.7

0.25

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

133

658

1.48

4.34

2.2

ug/min

99.5

122.2

0.16

151

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

158

809

1.43

4.32

1.3

1.2

—

(3044009) aPTT.lupus sensitive (LA screen)

2.33

4.24

1.1

1.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

163

843

1.42

4.23

1.6

1.4

umol/l

78.4

71.6

—

(3011288) Drugs identified in Urine by Screen method

204

2001

0.74

4.23

4.1

3.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

1084

0.65

4.22

1.0

—

(3006245) CD3-CD19+ cells/100 cells in Blood

104

492

1.55

4.20

2.4

2.7

13.7

11.3

0.62

455

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

169

881

1.40

4.20

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

128

1351

0.69

4.16

1.1

u/ml

1.9

4.6

3.33

544

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

346

1.65

4.11

1.4

1.2

30.3

40.1

1.56

229

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

169

886

1.40

4.08

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

168

880

1.40

4.07

1.1

—

(40768800) Prostate Pathology biopsy report

453

4013

0.82

4.05

1.2

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.35

4.04

1.2

1.3

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

657

0.57

4.03

13.3

12.2

mmol/l

0.6

0.05

597

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

261

1.74

3.96

1.1

1.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

107

517

1.51

3.95

1.7

2.0

umol/l

78.9

135.3

2.78

276

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

192

1034

1.36

3.95

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

168

886

1.39

3.93

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

147

758

1.42

3.91

1.8

1.4

u/l

7.3

5.9

0.49

118

634

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

466

1.54

3.90

1.2

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

102

490

1.52

3.88

2.3

2.5

28.4

29.1

0.15

463

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

520

3173

1.20

3.87

1.1

u/ml

9.8

7.8

0.25

351

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

345

3126

0.80

3.86

1.9

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

319

1.65

3.84

1.1

1.2

pmol/l

401.8

256.6

1.05

234

(3010726) Horse dander IgE Ab [Units/volume] in Serum

166

1651

0.73

3.82

1.0

1.1

u/ml

1.8

2.3

0.16

413

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

428

2572

1.22

3.74

1.5

1.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

219

2087

0.76

3.74

1.5

—

(3024263) Appearance of Synovial fluid

138

711

1.42

3.71

1.6

1.7

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.47

3.70

1.3

1.5

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

138

712

1.42

3.69

1.3

1.2

u/l

236.1

397.0

1.52

129

663

(3013637) Mi-2 Ab [Presence] in Serum

312

1.64

3.66

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

312

1.64

3.66

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

312

1.64

3.66

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

312

1.64

3.66

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

110

545

1.48

3.64

2.1

2.4

umol/l

52.7

53.9

0.14

449

(44816559) Phosphatidylethanol [Mass/volume] in Blood

364

2158

1.24

3.64

1.5

1.3

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

410

1.55

3.63

2.4

3.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

128

1311

0.71

3.56

1.4

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.47

3.55

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

107

1124

0.69

3.46

1.0

u/ml

0.2

0.6

1.15

303

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

2.28

3.42

1.8

1.7

mg/l

1.5

1.1

0.18

(3010838) Calcium [Moles/time] in 24 hour Urine

134

699

1.40

3.40

1.6

1.7

mmol/24h

6.4

5.2

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

2.31

3.37

1.0

1.1

u/field

1.0

1.1

0.31

(36660697) Celiac disease serology panel - Serum

1519

10097

1.11

3.36

1.2

—

(3013293) Extractable nuclear Ab [Presence] in Serum

171

1.84

3.36

1.3

1.5

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

2.85

3.36

1.0

1.2

u/field

1.0

1.6

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

586

0.59

3.35

1.3

1.4

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

124

1262

0.72

3.35

1.1

u/ml

3.1

5.0

1.11

513

(3008116) Ketones [Moles/volume] in Urine by Test strip

261

1.65

3.22

1.5

1.3

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

143

762

1.37

3.22

1.1

nmol/l

10.5

7.2

0.24

146

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

113

578

1.43

3.22

1.2

1.1

—

(3045424) Erythrocytes [Presence] in Urine

394

2389

1.21

3.21

1.5

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

2.25

3.19

1.8

1.7

mg/l

3.7

4.1

0.09

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

2.25

3.19

1.8

1.7

mg/l

1.6

1.7

0.09

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

2.25

3.19

1.8

1.7

mg/l

1.5

1.6

0.05

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

2.25

3.19

1.8

1.7

mg/l

0.6

1.4

0.64

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

2.25

3.19

1.8

1.7

mg/l

1.7

2.0

0.09

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

2.25

3.19

1.8

1.7

mg/l

0.7

1.6

1.24

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

2.25

3.19

1.8

1.7

mg/l

2.4

4.0

0.71

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

2.25

3.19

1.8

1.7

mg/l

2.0

0.8

0.42

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

2.25

3.19

1.8

1.7

mg/l

4.5

2.6

0.44

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1142

7501

1.12

3.18

1.2

iu/ml

116.3

142.4

1.43

380

2736

(3008536) Aspergillus sp Ab [Presence] in Serum

274

1.63

3.15

1.7

2.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

999

0.69

3.13

1.2

1.3

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

455

1.48

3.13

1.7

1.4

iu/ml

2427400.0

1016240.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

533

3332

1.17

3.09

1.4

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

104

2.04

3.06

1.1

1.2

umol/24h

1.7

1.6

0.09

104

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

193

1.74

3.05

1.4

1.6

—

(40765096) Chromosome analysis panel by Banding

428

1.49

3.05

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

512

3195

1.17

3.04

1.2

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

117

610

1.40

3.02

1.7

1.5

ug/l

8.6

8.3

0.10

104

552

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

115

1.97

2.99

2.6

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

395

3431

0.84

2.97

1.5

1.4

iu/l

28.9

30.5

0.40

329

2861

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

325

1.55

2.96

1.1

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

297

1767

1.23

2.95

3.7

3.4

nmol/l

16.0

8.9

0.67

284

1727

(3025130) Human papilloma virus identified in Specimen

123

1225

0.73

2.95

1.5

1.7

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

460

0.57

2.87

1.3

1.2

—

(3020491) Glucose [Moles/volume] in Blood

174

974

1.31

2.87

1.6

1.9

mmol/l

7.2

6.9

0.71

119

679

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

191

1086

1.29

2.81

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

543

3428

1.16

2.81

1.3

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

359

1.51

2.80

1.8

1.5

ug/l

0.4

0.22

228

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

318

1.54

2.80

1.1

—

(40768441) Liver Pathology biopsy report

186

1058

1.29

2.74

1.4

1.3

—

(3026470) Cobalt [Mass/volume] in Blood

184

1046

1.29

2.73

2.0

1.9

ug/l

4.0

3.3

0.51

164

913

(3023410) Appearance of Cerebral spinal fluid

149

1423

0.76

2.71

1.7

1.9

—

(3025577) Chromium [Mass/volume] in Blood

178

1009

1.29

2.70

2.1

2.0

ug/l

2.4

2.3

0.14

155

831

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

246

1.60

2.69

1.2

mg/l

135.7

34.9

0.46

196

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

460

0.59

2.69

2.6

2.5

nmol/l

158.7

149.7

0.11

392

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

180

1.71

2.64

1.3

1.2

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.55

2.62

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2054

14006

1.08

2.60

1.5

1.6

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

814

5319

1.12

2.55

1.1

u/ml

11.9

2.8

0.42

(3004347) Hepatitis D virus Ab [Presence] in Serum

3.18

2.51

1.0

—

(3006969) Lambda light chains [Mass/volume] in Urine

2.74

2.39

1.1

1.0

g/l

0.0

—

(1002224) Polysomnography panel

589

4870

0.88

2.37

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

206

1856

0.81

2.35

1.0

1.1

u/ml

5.3

4.4

0.32

974

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

205

1206

1.24

2.35

1.3

nmol/l

1.4

0.23

183

1094

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

193

1.63

2.32

1.6

1.7

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

336

2081

1.18

2.29

1.5

1.6

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

200

1801

0.81

2.28

1.0

1.1

u/ml

1.0

1.1

0.12

827

(44813793)

152

866

1.28

2.28

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

881

0.73

2.28

1.8

1.7

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

955

0.74

2.25

1.5

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

264

1.52

2.25

1.1

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

4.87

2.24

1.0

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

234

2063

0.83

2.18

1.1

u/ml

2.3

1.4

0.45

888

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

3.44

2.14

1.8

3.5

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

862

0.74

2.13

1.6

1.5

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.91

2.11

1.4

1.9

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

153

1.67

2.11

3.3

2.7

mg/l

1.2

1.3

0.17

109

(3015076) Soybean IgE Ab [Units/volume] in Serum

561

0.68

2.09

1.1

u/ml

0.4

1.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

732

0.72

2.08

1.4

1.5

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

111

615

1.32

2.08

1.4

1.2

58.4

64.8

0.27

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

689

0.71

2.07

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

372

1.42

2.07

2.5

2.7

e6/l

166.4

1014.8

0.83

221

(3035082) Kappa light chains [Mass/volume] in Urine

2.51

2.05

1.2

1.1

g/l

0.0

0.4

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

501

4135

0.88

2.02

1.8

1.7

nmol/l

45.6

42.3

2.34

481

4008

(3018851) Theophylline [Moles/volume] in Serum or Plasma

111

1.78

2.01

1.6

1.7

umol/l

50.1

42.7

0.47

111

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

2.59

2.01

1.5

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

180

1066

1.24

2.00

1.4

promille

1.1

1.4

1.56

126

830

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

360

0.61

1.98

1.5

2.4

—

(40768793) Breast Pathology biopsy report

346

2924

0.86

1.98

1.3

—

(3022621) pH of Urine by Test strip

1356

9213

1.08

1.96

3.5

2.9

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

147

853

1.26

1.96

1.4

1.3

u/ml

1.7

1.3

0.21

412

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.86

1.95

1.1

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

2.44

1.95

1.0

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

303

0.58

1.94

2.5

2.9

ng/l

171.7

114.6

0.50

143

(3046904) Somatotropin [Units/volume] in Serum or Plasma

3.08

1.93

6.0

1.4

mu/l

2.9

1.6

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.22

1.89

1.1

pmol/l

197.4

190.5

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

169

1001

1.23

1.89

1.2

mmol/l

11.6

12.1

0.34

299

(40768795) Lymph node Pathology biopsy report

234

1433

1.19

1.88

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1235

8377

1.08

1.88

1.3

au/ml

68.8

54.3

0.75

374

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

129

1186

0.79

1.85

1.0

ng/l

329.8

333.2

0.05

827

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

241

1.49

1.85

1.1

1.2

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

124

0.41

1.82

1.0

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

150

883

1.24

1.79

1.8

2.2

umol/l

13.7

10.8

0.31

109

650

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

583

3828

1.12

1.79

1.9

1.7

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

174

1042

1.22

1.78

2.4

2.6

nmol/l

17.3

17.7

0.19

164

997

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1356

9253

1.07

1.77

2.5

2.4

au/ml

35.5

26.8

0.79

461

(3000285) Sodium [Moles/volume] in Blood

167

1.58

1.77

1.4

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

255

2183

0.85

1.77

1.1

iu/ml

81.6

5392.0

0.56

453

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

102

575

1.30

1.74

1.0

—

(3028707) Methadone [Presence] in Urine by Screen method

152

1362

0.81

1.74

2.9

2.8

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

2.78

1.74

1.1

1.0

titre

2880.0

1841.4

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

106

1.72

4.4

6.2

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.85

1.72

5.9

5.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

996

6735

1.08

1.67

1.7

1.6

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

132

1193

0.81

1.66

1.0

ng/l

44.0

42.6

0.16

821

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

192

1672

0.84

1.65

1.1

1.2

mmol/l

7.5

0.05

140

1189

(3006567) Chloride [Moles/time] in 24 hour Urine

2.66

1.65

1.3

1.1

—

(44806420)

421

1.34

1.64

2.2

2.4

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

378

2433

1.14

1.64

1.3

miu/ml

159.9

212.8

2.08

119

1017

(3009015) Lactate [Moles/volume] in Synovial fluid

159

1.56

1.63

1.4

1.3

mmol/l

5.9

6.2

0.11

(4035726)

1948

13494

1.06

1.63

1.5

1.4

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

132

1190

0.81

1.63

1.0

ng/l

742.5

728.8

0.11

798

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.73

1.62

1.5

1.2

—

(3051101) Glucose [Moles/volume] in Cord blood

314

0.63

1.62

4.2

6.0

—

(3018133) Calcium [Moles/volume] in Urine

255

1.43

1.61

1.9

2.3

mmol/l

2.5

2.6

0.14

226

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

106

0.41

1.55

1.0

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.92

1.54

1.1

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.01

1.51

12.2

8.4

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

1.76

1.50

1.2

1.5

pmol/l

14.7

17.9

0.36

(3006598) pH of Arterial cord blood

126

0.46

1.49

1.0

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.78

1.48

1.2

1.3

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

3.32

1.45

1.0

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

194

1.47

1.45

1.5

1.4

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

186

0.55

1.43

1.2

1.1

u/ml

42.5

66.7

1.30

178

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

166

0.53

1.40

2.8

1.8

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.93

1.38

1.0

1.1

—

(3044336) Cobalt [Moles/volume] in Urine

0.00

1.37

0.0

2.7

—

30.7

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

371

1.32

1.36

1.2

1.3

nmol/l

103.4

126.8

1.15

252

(3049242) von Willebrand panel - Platelet poor plasma

2.11

1.36

1.9

1.5

—

(3036048) Francisella tularensis Ab [Titer] in Serum

327

1.34

1.36

1.1

1.2

—

818.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

367

2997

0.89

1.35

1.9

1.7

mu/l

322.1

293.5

0.86

332

2744

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

711

0.78

1.35

1.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

182

0.56

1.34

5.1

2.8

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.89

1.32

1.0

1.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

181

0.56

1.32

10.1

5.5

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

341

0.69

1.32

1.9

1.8

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

2.44

1.31

1.0

—

(3007463) Buprenorphine [Presence] in Urine

2.44

1.31

11.6

7.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

342

1.33

1.31

2.1

2.5

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

163

1.48

1.29

1.2

1.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.41

1.27

1.0

1.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

228

1449

1.15

1.27

1.8

1.9

titre

817.8

2610.3

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

408

1.29

1.26

1.3

1.2

34.8

17.4

0.95

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

182

1138

1.17

1.25

1.4

u/l

32.7

28.8

0.75

146

940

(37021550) Renin [Units/volume] in Plasma --upright

294

1.34

1.25

1.1

1.2

mu/l

97.6

58.3

0.70

221

(3001186) Copper [Moles/volume] in Serum or Plasma

313

1.33

1.25

1.2

umol/l

17.9

16.6

1.33

281

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

195

1.42

1.24

1.0

1.1

—

(4212803)

129

1.53

1.24

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

159

1.47

1.23

2.4

2.9

u/field

0.7

0.5

0.37

159

(3035933) Granulocytes/100 leukocytes in Blood

369

0.71

1.22

1.4

1.6

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

278

1.34

1.19

1.2

—

(3002619) Bacteria identified in Specimen by Culture

285

1.33

1.17

1.2

1.3

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

174

1.43

1.15

1.0

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

275

1.33

1.11

1.1

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

152

949

1.17

1.10

2.8

2.2

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.76

1.10

1.1

1.5

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

385

1.27

1.09

1.2

1.7

—

616.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

124

762

1.19

1.09

1.1

—

(3009992) Blasts/100 cells in Bone marrow

2.44

1.08

1.8

1.5

17.6

13.9

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

645

0.80

1.04

1.1

u/ml

3.2

7.0

0.43

194

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.60

1.03

1.1

1.0

—

(3024869) Neuronal Ab [Presence] in Serum

279

1.31

1.03

1.1

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.93

1.02

1.3

1.2

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

461

1.24

1.02

1.3

1.4

umol/l

2.6

3.8

3.59

422

(3029396) Erythrocyte agglutination [Presence] in Blood

149

0.59

1.02

2.7

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.65

1.01

1.1

1.4

—

(3016244) Insulin [Units/volume] in Serum or Plasma

111

681

1.19

1.01

3.0

3.1

mu/l

29.8

25.5

0.34

641

(3029075) Extractable nuclear Ab panel - Serum

351

1.27

1.00

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

364

2916

0.91

1.00

1.5

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

164

1040

1.15

1.00

1.8

1.7

—

(46235168) Fasting glucose [Moles/volume] in Blood

148

0.59

1.00

16.3

1.4

mmol/l

8.1

7.2

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.88

1.00

1.8

1.0

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.99

0.0

1.3

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

180

1.38

0.98

1.4

1.6

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

101

1.52

0.97

1.1

u/l

9.0

9.9

0.12

101

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

167

1063

1.15

0.97

1.4

1.3

mmol/l

2.3

2.1

0.67

152

989

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

115

712

1.18

0.96

1.2

1.3

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

259

0.70

0.95

1.0

1.1

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.75

0.94

1.2

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

275

0.72

0.93

1.4

1.5

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1948

14753

0.96

0.92

1.7

1.8

1.6

1.5

6.33

1634

12785

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

262

1727

1.11

0.89

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

585

1.19

0.87

1.2

1.1

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

185

0.67

0.85

1.2

u/ml

0.0

13.5

2.76

142

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

149

1.37

0.82

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

672

0.84

0.81

1.1

u/ml

0.6

2.5

2.12

235

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

480

0.81

1.1

1.2

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

139

0.63

0.81

1.2

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.72

0.81

1.0

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.80

0.0

1.1

—

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

0.00

0.80

0.0

1.1

—

12.6

—

(4133840)

357

1.23

0.79

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

357

1.23

0.79

1.1

—

(40762814) Titanium [Mass/volume] in Blood

298

1.25

0.79

2.5

2.3

ug/l

3.0

3.5

0.62

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

169

1.34

0.79

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

120

0.61

0.78

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

289

1934

1.09

0.76

1.4

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

595

0.83

0.76

1.4

1.2

—

(40762887) Creatinine [Moles/volume] in Blood

1.83

0.73

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

295

0.77

0.73

1.1

1.0

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

103

1.42

0.71

1.1

—

(3033942) Copper [Moles/time] in 24 hour Urine

1.64

0.71

1.1

umol/24h

0.3

0.9

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

198

1.29

0.71

1.1

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

431

2947

1.07

0.69

1.7

nmol/l

0.9

0.8

2.83

361

2463

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.66

0.68

1.0

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.43

0.67

1.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.43

0.67

3.9

5.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

828

6322

0.96

0.64

3.0

4.0

u/ml

45.6

63.1

1.57

781

6109

(3023511) Choriogonadotropin [Units/volume] in Urine

111

918

0.88

0.63

1.5

1.3

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.58

0.63

1.0

1.2

nmol/l

207.4

321.3

1.51

(3015183) Erythrocyte sedimentation rate

543

0.85

0.63

1.8

1.2

—

(4281824)

224

1500

1.09

0.62

1.3

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

205

0.75

0.62

1.0

1.1

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.61

0.0

1.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.62

0.59

1.4

1.1

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.51

0.59

4.7

4.5

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

198

1.25

0.58

1.1

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

198

1.25

0.58

1.1

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

172

1.27

0.58

1.0

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

108

1.35

0.57

1.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

115

748

1.12

0.57

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

794

0.88

0.57

1.4

1.6

—

(3016018) Differential panel - Cerebral spinal fluid

195

1551

0.92

0.56

1.5

—

(3030313) Adrenal Ab [Titer] in Serum

1.44

0.56

1.1

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.53

0.55

1.2

1.4

nmol/l

420.9

583.4

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

207

1.24

0.54

1.7

1.8

pmol/l

85.9

50.3

0.47

170

(3051387) C reactive protein [Mass/volume] in Capillary blood

414

3198

0.94

0.54

4.7

3.1

mg/l

29.0

27.7

0.31

282

1954

(3009466) Valproate [Moles/volume] in Serum or Plasma

252

1977

0.93

0.53

4.0

5.0

umol/l

360.2

362.2

0.08

223

1680

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

900

6337

1.04

0.52

1.0

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

203

1369

1.08

0.52

1.5

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

609

1.13

0.52

1.2

1.1

ng/l

862.7

727.7

0.07

144

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

413

0.85

0.50

1.3

1.2

g/l

0.3

0.84

334

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

216

1.22

0.50

1.2

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

297

1.18

0.49

1.6

1.8

au/ml

160.8

128.1

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

1.44

0.48

5.7

4.5

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

403

3102

0.95

0.48

1.5

1.6

e6/l

2611.5

3142.6

0.11

346

2522

(3001556) Androgen free Index in Serum or Plasma

1.46

0.48

1.7

1.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

134

893

1.10

0.46

2.0

1.7

—

(3014051) Protein [Presence] in Urine by Test strip

447

3110

1.05

0.46

2.5

2.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

657

0.89

0.46

1.3

1.6

ug/l

2.8

5.5

2.28

508

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

403

3096

0.95

0.46

1.4

1.5

e6/l

63.2

27.1

0.58

330

2401

(3012494) Peanut IgE Ab [Units/volume] in Serum

327

1.16

0.45

1.1

u/ml

0.8

15.5

0.84

189

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

186

0.79

0.45

1.5

1.1

mmol/l

21.5

20.2

0.91

154

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

293

2017

1.06

0.45

2.1

2.2

u/l

3201.9

4591.2

0.38

739

(43055514) Macroprolactin [Presence] in Serum or Plasma

186

1.22

0.44

2.1

1.3

—

(4027681)

709

0.90

0.44

1.3

1.2

—

(3012989) Citrate [Moles/time] in 24 hour Urine

1.66

0.44

1.2

1.3

mmol/24h

1.3

2.6

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.33

0.43

1.2

1.1

—

(3003577) Lead [Moles/volume] in Blood

1.33

0.43

1.1

1.3

umol/l

0.1

0.2

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.43

0.43

8.5

6.3

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

152

0.77

0.42

1.0

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1592

11901

0.98

0.42

2.1

nmol/l

12.2

12.8

2.21

1350

10534

(3041806) Other cells [#/volume] in Blood by Manual count

184

0.79

0.42

1.7

1.6

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.42

0.0

1.0

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

1.35

0.41

1.1

u/l

55.9

160.3

0.60

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.41

0.0

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.43

0.40

1.0

—

(3036005) Urine sediment comments by Light microscopy Narrative

0.00

0.40

0.0

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

338

1.15

0.40

1.5

1.9

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

244

1680

1.06

0.39

1.2

—

(3049233) Organic acids panel - Urine

1.40

0.38

1.0

1.2

—

(3022689) Creatine [Moles/volume] in Urine

448

0.88

0.38

1.4

1.5

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

554

1.11

0.38

1.0

1.1

u/ml

4.3

8.5

1.09

(3022475) Manganese [Moles/volume] in Blood

0.69

0.37

1.4

1.3

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

385

0.87

0.37

1.2

108.8

112.5

0.43

342

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

264

1827

1.06

0.37

1.1

au/ml

10.4

13.3

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

156

0.80

0.36

1.0

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

789

0.92

0.35

1.3

g/l

1.5

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

123

969

0.93

0.34

1.1

mg/l

47.1

44.5

0.19

823

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

118

931

0.93

0.34

1.1

mg/l

305.6

295.7

0.15

102

824

(3032352) Blasts [#/volume] in Cerebral spinal fluid

186

0.82

0.33

2.0

2.7

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

365

1.12

0.33

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

1.38

0.32

1.3

1.2

—

(3042517) Benzodiazepines panel - Urine

1.28

0.31

3.9

2.4

—

(3028717) Thiamine [Mass/volume] in Blood

120

1.22

0.31

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

207

0.85

0.30

1.5

2.1

umol/l

16.3

17.4

0.21

207

(3001729) Color of Synovial fluid

114

1.22

0.29

1.7

1.6

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

681

0.92

0.29

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

1.27

0.28

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.76

0.28

1.6

1.3

umol/24h

251.2

358.8

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.30

0.27

1.4

u/field

1.2

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

206

1578

0.95

0.27

1.1

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

343

2598

0.96

0.26

1.4

pmol/l

130.9

175.9

1.92

334

2535

(3034092) Cytoplasmic Ig cells/100 cells in Blood

184

1.15

0.26

9.1

8.7

—

(3002523) Influenza virus A Ag [Presence] in Specimen

206

1576

0.95

0.26

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

114

781

1.07

0.26

1.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

473

3559

0.97

0.25

1.4

mg/l

577.9

555.3

0.37

452

3382

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

120

824

1.06

0.25

6.1

6.7

—

(3008898) HLA-B27 [Presence]

475

3573

0.97

0.25

1.0

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

387

1.09

0.25

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

165

1.15

0.24

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.25

0.24

1.1

1.6

—

(3005011) Chlamydia sp Ab [Titer] in Serum

179

1.14

0.23

1.8

1.6

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

324

0.90

0.23

1.3

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

537

1.07

0.23

1.1

—

(40758358) Immune stain study

0.75

0.23

1.0

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

1.26

0.22

1.0

1.6

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

173

1.14

0.22

1.0

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

262

0.89

0.22

1.7

1.9

ug/l

2.1

2.6

0.53

151

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.20

0.22

1.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.20

0.22

1.1

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

1.20

0.22

1.1

1.6

17.0

10.6

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

107

0.82

0.22

1.3

1.9

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

0.22

0.0

1.0

—

26.1

—

(3000034) Microalbumin [Mass/volume] in Urine

196

1373

1.04

0.22

3.2

3.0

mg/l

61.7

38.3

0.77

146

977

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

160

1.14

0.21

1.0

1.1

—

(40758292) HTLV I+II Ab panel - Serum

230

1.11

0.20

1.4

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.24

0.20

1.5

1.4

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

415

1.07

0.18

1.2

1.1

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.22

0.18

1.0

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

366

1.08

0.18

1.1

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.19

0.18

1.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

394

0.93

0.18

1.2

1.5

mmol/l

8.3

8.2

0.02

231

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

395

2956

0.98

0.18

2.0

1.9

pmol/l

187.8

202.2

2.34

370

2785

(40760410) HLA-B [Type] by High resolution

0.75

0.17

1.0

—

(40763590) HLA-DQ beta [Type]

0.75

0.17

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.75

0.17

1.0

—

(40760409) HLA-A [Type] by High resolution

0.75

0.17

1.0

—

(3013862) HLA-DP [Type]

0.72

0.17

1.0

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

226

0.90

0.16

1.1

—

2.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

202

1523

0.97

0.16

1.1

u/ml

2.7

3.7

0.75

620

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

305

1.08

0.16

1.2

1.3

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

370

1.07

0.15

1.9

2.1

mg/l

7.6

9.6

2.17

298

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

321

1.07

0.14

1.1

1.2

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.82

0.14

1.3

1.2

1.3

1.4

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

201

1.09

0.13

1.9

1.6

nmol/l

0.2

0.25

140

(3009214) Lutropin [Units/volume] in Serum or Plasma

427

3061

1.02

0.13

1.5

1.4

u/l

12.1

9.6

2.67

341

2439

(3011048) Pyruvate [Moles/volume] in Blood

0.83

0.13

1.0

1.2

umol/l

99.0

82.4

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

182

1368

0.97

0.13

1.1

—

77.8

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

625

0.96

0.12

1.1

1.3

mmol/l

6.0

6.1

0.07

596

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

146

0.90

0.12

1.2

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

108

0.88

0.12

1.0

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

113

797

1.04

0.12

1.0

1.1

iu/ml

13.9

9.3

0.89

170

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

117

884

0.97

0.11

1.1

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

138

0.90

0.11

1.2

1.3

mmol/l

—

1.0

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

225

1.07

0.11

1.1

1.4

53.1

53.5

0.02

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

655

1.04

0.11

1.0

1.1

u/l

1.1

0.18

322

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

179

1277

1.02

0.10

1.7

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.14

0.10

1.3

1.2

—

(3020650) Glucose [Presence] in Urine

339

0.95

0.10

1.3

1.5

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

144

0.91

0.09

1.1

ug/l

115.5

82.0

1.49

112

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

368

0.95

0.09

1.4

1.2

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

0.88

0.09

1.0

u/ml

0.0

2.3

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

120

1.10

0.09

1.1

u/ml

0.0

0.2

0.56

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

170

1.07

0.08

1.6

2.4

mmol/l

1.1

1.6

0.63

121

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.07

0.08

1.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

128

0.91

0.08

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

171

1.07

0.07

1.2

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

257

1.05

0.07

1.0

u/ml

15.6

12.0

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

114

1.09

0.07

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

430

3106

1.01

0.07

1.4

mmol/l

3.9

3.8

0.66

399

2925

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

387

0.96

0.07

2.7

3.7

mg/l

6.7

7.4

0.43

314

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

154

1146

0.98

0.06

1.4

nmol/l

0.4

0.3

0.47

108

858

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

215

1.05

0.06

1.3

1.2

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

194

1395

1.02

0.06

3.1

3.8

u/ml

35.3

57.0

2.12

188

1374

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

386

0.97

0.06

1.5

1.8

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2614

19029

1.00

0.06

1.4

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

274

0.96

0.05

2.9

6.2

u/l

49.0

70.2

0.50

100

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

118

0.93

0.05

1.2

1.4

nmol/l

21.5

15.7

—

(3032868) Hemoglobin electrophoresis panel in Blood

103

0.92

0.05

1.5

1.6

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

164

1215

0.99

0.05

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.92

0.04

1.2

1.1

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

353

0.97

0.04

2.3

3.0

au/ml

270.6

163.8

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.92

0.03

1.0

1.1

—

(3017509) Phencyclidine [Presence] in Urine

0.92

0.03

3.3

1.6

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

389

0.98

0.03

1.2

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

109

0.94

0.03

3.4

3.6

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

101

727

1.01

0.03

1.2

1.3

—

(40765089) Chromosome analysis panel - Blood by G-banded

226

1.03

0.03

1.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.93

0.03

1.0

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

159

1171

0.99

0.02

4.8

5.1

u/ml

108.8

114.5

0.03

354

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

133

1.04

0.02

1.1

1.2

16.1

24.4

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

104

1.05

0.02

1.3

1.6

46.9

35.9

—

(4198724)

401

0.98

0.01

1.9

2.2

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.07

0.01

1.0

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

101

744

0.99

0.01

4.0

5.5

u/ml

52.4

5816.8

—

139

(44806071)

165

0.97

0.00

1.0

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.00

0.00

1.2

1.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

113

0.97

0.00

1.8

2.8

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

383

0.99

0.00

1.2

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.03

0.00

1.0

1.1

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

1.03

0.00

3.2

3.7

—

0.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

388

1.00

0.00

1.2

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

526

1.00

0.00

3.0

umol/l

31.1

28.3

1.45

404

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.90

0.00

1.3

1.2

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.91

0.00

1.0

1.1

—

(3019529) Immunofixation for Cerebral spinal fluid

0.00

0.0

1.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.93

0.00

1.1

1.5

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.93

0.00

5.8

2.7

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

8.2

—

(36304079) Mucus [Presence] in Urine sediment

0.00

0.0

1.2

—

(3015531) Creatine kinase.macromolecular [Enzymatic activity/volume] in Serum or Plasma

0.00

0.0

1.2

—

0.0

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3013762) Body weight Measured

1.02

0.00

1.2

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint I9_VHD and mortality.

Females

Parameter	HR [95% CI]	p-value
I9_VHD	1.782 [1.63, 1.94]	< 0.001
Birth year	0.99 [0.98, 1.0]	0.012

During the follow-up period (1.1.1998 — 31.12.2019), 31009 out of 80488 females with I9_VHD died.

Males

Parameter	HR [95% CI]	p-value
I9_VHD	1.65 [1.5, 1.81]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.015

During the follow-up period (1.1.1998 — 31.12.2019), 28964 out of 79155 males with I9_VHD died.

Mortality risk

Mortality risk for people of age

years, who have I9_VHD.

N-year risk	Females	Males
1	0.127%	0.282%
5	0.69%	1.671%
10	1.911%	4.544%
15	3.775%	8.684%
20	6.546%	14.849%

Relationships between endpoints

↥

Index endpoint: I9_VHD – Valvular heart disease excluding rheumatic fever

GWS hits: 16

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Valvular heart disease excluding rheumatic fever

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints